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Neutrophils are often early responders to pulmonary damage, rapidly infiltrating 
the lungs to promote tissue repair following exposure to harmful stimuli.  A single dose 
of intratracheally (IT)-administered elastase results in acute inflammation and 
progressive emphysematous damage that is also accompanied by a transient and robust 
neutrophil influx. However, the importance of this early neutrophil recruitment in the 
chronic progression of emphysema is not well understood.  This work seeks to better 
define the dynamics of pulmonary neutrophil migration in the elastase model of 
emphysema and to address the hypothesis that the early influx of neutrophils into the 
lungs contributes to the resolution of acute elastase-mediated injury and affords 
protection to the lungs from the progressive alveolar destruction that is associated with 
emphysema. 
Bronchoalveolar lavage (BAL) samples were examined by light microscopy at 
acute time points post-porcine pancreatic elastase administration (post-PPE) to map the 
cellular response to three enzymatic units of IT elastase in neutrophil-intact BALB/c 
mice.  Systemic depletion of neutrophils was accomplished using a single 500 μg dose of 
anti-mouse Ly-6G antibody (clone 1A8) injected intraperitoneally (IP) 24 hours prior to 
elastase treatment.  BAL cell counts, total lung capacity (TLC), diffusion factor for carbon 
monoxide (DFCO), and mean airspace chord lengths (Lm) were each evaluated for effects 
of neutrophil depletion. 
Neutrophils in BAL fluid from control animals were found to peak approximately 
24 hours post-PPE before returning to baseline by 72 hours.  Treatment with 1A8 
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resulted in sustained depletion of neutrophils for approximately 5 days that, as 
expected, ablated the early influx of neutrophils following PPE administration.  
Neutrophil-depleted mice were found to have no significant exacerbation of 
emphysematous damage post-PPE.  These results do not support the hypothesis that 
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Emphysema is characterized by the progressive destruction of alveoli 
accompanied by a reduction in ventilation and gas exchange (Mayo Clinic).  It is grouped 
together with chronic bronchitis under a blanket of symptoms referred to as chronic 
obstructive pulmonary disease (COPD).  Histologically, an emphysematous lung has wide 
air spaces, few dividing septa, and lacks the grape-like structure that lends a healthy 
lung its high surface area for efficient gas exchange.  Emphysema patients are often 
short of breath, lethargic, and have a rapid pulse.  These symptoms result because too 
little oxygen is able to diffuse across alveoli into pulmonary vessels to meet the body’s 
demands.  COPD patients are also at greater risk for airway infections.  Whether these 
infections contribute to the disease or result from it is unclear.  Environmental factors 
such as smoke, pollution, fumes, and dust can contribute to the development of 
emphysema.  Emphysema does not appear to result from a single exposure.  Rather, 
repeat exposures over years and years seems to drive disease.  Habitual smokers 
comprise the vast majority of cases.  But second-hand smoke and occupational 
exposures contribute to the prevalence of emphysema as well.  Genetics is believed to 
be a contributing factor, but with the exception of a heritable deficiency in alpha 1-
antitrypsin the mechanism is unclear.  Evidence supporting the role of genetics includes 
habitual smokers who never develop emphysema despite extensive exposure to a 
known risk factor. 
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The protease-antiprotease hypothesis, depicted in Figure 1 (1), is the oldest and 
most studied mechanism for emphysema.  This hypothesis posits a scenario in which 
lung damage drives the infiltration of neutrophils that release copious amounts of 
extracellular matrix-degrading enzymes, such as elastase.  This elastase spike 
overwhelms the neutralizing power of local antiprotease molecules and extensive 




Neutrophil expressed elastase (ELANE), IL-8 (the neutrophil chemotactic 
chemokine CXCL8), and MMP9 (matrix metallopeptidase 9; type IV collagenase; 
macrophage gelatinase) were all found to be elevated in COPD patient sputum and 
correlate with disease severity (2).  The marked presence of matrix metallopeptidases 
and neutrophil elastase in smoker lungs is established, that they play a role in alveolar 
Figure 1: A cigarette smoke-induced mechanism of the protease-antiprotease hypothesis. 
3 
 
destruction is very likely, but that neutrophils are the primary source has yet to be 
determined (3).  Macrophages can secrete neutrophil elastase taken up from 
neutrophils (4).   Matrix metalloproteinase 12 (MMP12), produced by macrophages, 
could deactivate the principle antiprotease responsible for neutralizing neutrophil 
elastase (3).  Cigarette smoke itself is enough to simultaneously induce elastase and 
reduce the activity of its inhibitors (3).  Rather than incriminate neutrophils, the 
protease-antiprotease hypothesis demonstrates the important role of the innate 
immune response in, at the very least, initiating emphysema.  The elastin and 
collagenous extracellular matrix that forms the scaffold on which epithelial cells 
assemble into the unique grape-like clusters is directly destroyed by elastase.  While this 
widely accepted hypothesis offers a mechanism that explains some aspects of alveolar 
destruction, it cannot account for all characteristics of the disease.   
The disease outcomes for patients with emphysema are poor.  While therapies 
do exist to slow the progression of emphysema and manage symptoms, the damage is 
lasting and irreversible.  Doctors can prescribe supplemental oxygen, steroids, and/or 
bronchodilators; but ultimately the best option for patients is to quit smoking and limit 
their exposure to known irritants. 
Emphysema costs the United States nearly 30 billion dollars annually (5).  
Approximately 4.7 million Americans – mostly adults above the age of 45 – suffer from 
emphysema, live a lower quality of life and will require more and more care as their 
disease progresses (5).  On a global scale, emphysema – as measured by COPD estimates 
– affects 210 million people (6).  Clearly this is a public health problem of enormous 
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reach.  Given the poor prognosis that accompanies an emphysema diagnosis, the 
strategy should focus on disease prevention.  This includes education, risk management, 
and research. 
Little is understood of how factors such as cigarette smoke induce such dramatic 
and progressive pathology.  The extent to which immune-mediated damage contributes 
to the disease has only been superficially characterized.  The research detailed in this 
thesis is intended to add to this body of knowledge.   Specifically, we seek to either 
absolve or incriminate polymorphonuclear leukocytes of a role in the development of 
emphysema. 
 
Immunology of Emphysema 
Emphysema is a chronic condition of sterile alveolar inflammation.  There is no 
evidence that pathogens initiate or promote the destruction of alveolar ultrastructure in 
smoke-induced emphysema, but that does not absolve infectious agents of a potential 
role.  The hookworm lifecycle has an obligatory lung phase and infection with 
hookworm parasites can initiate emphysematous changes (7).  Retamales and 
colleagues published in 2001 that a greater degree of emphysematous pathology 
correlated with higher levels of adenovirus envelope protein expression (8).  However, 
existing pathology could predispose a COPD patient to adenovirus infection.  That the 
original pathology was caused by infection is not necessarily the case.  On a similar note, 
macrolide research indicates this class of antibiotics is useful in decreasing the severity 
of COPD (9).  Macrolides work by inhibiting protein synthesis and are considered 
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effective broad-spectrum antibiotics, but recent findings suggest certain macrolides also 
have anti-inflammatory properties.  Deciphering which macrolide property – 
antimicrobial or immunomodulatory – is responsible for its therapeutic effects in COPD 
management is of greater interest.  Perhaps it is a combination of both.  There is 
evidence that products of the innate immune system – initially released into the lung to 
respond to cellular damage – actually contribute to airway damage (4).  A better 
understanding of emphysema immunology could lead to earlier and more accurate 
diagnosis, effective treatments, and novel prevention strategies.  If specific cells, 
cytokines, and activation states are found to correlate with emphysema, assays that 
detect these could diagnose a patient long before physiological symptoms become 
manifest.  If specific cell types or immune mediators are discovered to contribute 
directly to disease, these could serve as targets for neutralizing antibodies or inhibitors.  
There is incredible potential for emphysema immunology research to translate to a 
clinical setting and benefit millions of people. 
In emphysema, whether the insult is chemical – for example toxins found in 
tobacco smoke – or particulate – such as asbestos – the epithelial cells lining the lung 
are damaged.  How epithelial cells become damaged is a more contentious topic.  There 
are two likely mechanisms.  First, the inhaled irritant directly damages epithelial cells.  
Many components of cigarette smoke are toxic – carbon monoxide, benzene, cyanide, 
etc. – and could turn on apoptotic pathways.  A second possibility is irritants are sensed 
by lung resident leukocytes – mainly macrophages and mast cells – and epithelial cells, 
which release factors that recruit polymorphonuclear cells from the blood.  These 
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resident and recruited cells are then triggered to produce effector molecules that exact 
damage on the lung epithelium.   
Evidence suggesting that Toll-like receptors (TLRs) may be involved in sensing 
these noninfectious irritants is mixed.  A study published in 2005 found that TLR 2 and 4 
were involved in the inflammatory response to sterile stimuli, specifically monosodium 
urate monohydrate (MSU) crystals – responsible for gout – and subcutaneous air 
injections (10).  Bone marrow-derived macrophages of TLR2 knockout (KO) mice and 
TLR4 KO mice were found to produce significantly less IL-1beta and TNF-α (10).  Another 
study implicated TLR 3 in the inflammatory response to ischemia under sterile 
conditions.  24 hours after the ischemic event, TLR3 KO mice had TNF-α levels 
approximately one-third those of normal mice (11).  This is particularly interesting in 
light of evidence for hypoxia following tobacco smoke inhalation (12).  TLRs classically 
sense microbial molecular patterns.  The idea that TLRs might have sterile triggers as 
well is provocative.  Curiously, similar studies found no evidence that TLRs were 
stimulated by sterile injury (13).   
The family of nucleotide-binding oligomerization domain (NOD)-like receptors 
(NLRs) are intracellular receptors, unlike TLRs which are found at the cell surface and in 
endosomal membranes.  NLRs typically cooperate with TLRs to generate appropriately 
focused inflammatory and apoptotic responses.  The literature generally supports a role 
for NLRs in sterile inflammation.  Dostert and colleagues published in 2008 that inhaled 
asbestos and silica activate the innate immune system via Nalp3, a member of the NLR 
family (14).  Asbestos and silica inhalation are documented risk factors for emphysema.  
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While asbestos and silica are particulate and thus diverge from the suspected stimuli in 
tobacco smoke, they do induce DAMPs like reactive oxygen species (ROS’s) which are 
known triggers of Nalp3.  Once activated, Nalp3 inflammasomes can stimulate dramatic 
increases in IL-1beta and other chemotactic factors.  In Dostert’s research, it was found 
that Nalp3 KO mice had a diminished cellular response to the irritants, including 
significantly fewer neutrophils (14).  A more recent study took this idea one step further.  
Nalp3 KO mice were found to have better outcomes to acute hypoxic injury as 
measured by increased epithelial cell survival (15).   
Other receptors involved in sensing signs of danger have been examined as well.  
The IL-1 receptor and its accompanying adaptor protein, MyD88, have been linked to 
sterile injury as drivers of inflammatory responses.  Gouty inflammation in response to 
monosodium urate (MSU) crystals is dependent on MyD88 – animals deficient in MyD88 
do not develop the pathology (16).  Similarly, IL-1R KO mice also have severely stunted 
inflammatory responses to MSU (16).  Administering antibody to block IL-1 interactions 
with its receptor has the same effect (16).  While MSU is a good model for studying 
sterile inflammation, it is unclear how applicable this model is to the sterile 
inflammation suspected of driving emphysema.  Another trigger, dying cells, might be a 
more logical connection.  Smoking tobacco does result in lung cell death (17).  A 2007 
study of dying cells confirmed that IP injections produced marked neutrophilic 
inflammatory responses in mice (18).  The study then demonstrated that IL-1R KO mice 
and MyD88 KO mice did not develop the expected inflammation.  It is interesting that 
the IL-1 pathway is a requirement of neutrophilic inflammation only in response to 
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sterile stimuli; it is not required when infection is driving the response.  While 
interesting, a single IP injection of dying cells is not equivalent to smoking a cigarette, 
for example, and any extrapolation of these results to emphysema would be premature. 
Another key point to keep in mind is that much of the research cited above is 
done on acute models.  Many diseases of sterile inflammation are in fact chronic – 
emphysema being a prime example.  The current body of literature should be used to 
guide the discovery of better chronic disease models. 
 
 
To summarize, how cells lining the lumen of the lung are damaged in response to 
irritants like tobacco smoke is not clear.  Apoptosis could be triggered directly by 
irritants and free radicals, or irritants could be detected and spur on inflammatory 
pathways known to cause cell damage.  Evidence for TLRs, IL-1R, and MyD88 as cellular 
Figure 2: Lung inflammation due to cigarette smoke involves inflammasome activation. 
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sensors for detecting irritants was presented; how they may fit into the greater schema 
is illustrated in Figure 2 (19).   
 
DAMPs and Tissue Damage 
Cell death and the initiation of inflammation represent only the beginning of a 
long and complex process, a process that can culminate with the development of 
emphysema.  The next step in this process is propagation of inflammation.  Cells, their 
cytokines and effector functions will be discussed next. 
Tissue damage drives the discharge of damage-associated molecular pattern 
molecules (DAMPs) into the extracellular compartment.  These include pro-IL-1α, heat 
shock proteins, hyaluronan fragments, ATP, adenosine, DNA, uric acid, and heparin 
sulfate – generally molecules that are not exposed to the extracellular compartment 
under normal conditions either because they are retained within cells or have lost their 
recognizable structure.  Recent work investigating high-mobility group box 1 (HMGB1), 
an intracellular molecule with DNA-binding sites and anti-apoptotic activity, has 
unmasked its huge immunogenic potential if released into the extracellular milieu, as 
occurs in sterile injury (20).  HMGB1 interacts with TLR2, RAGE, and TLR4 to elicit the 
expression/release of intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion 
molecule (VCAM-1), TNF-α, IL-8, and monocyte chemotactic protein 1 (MCP-1), among 
other factors (20), which together activate endothelial cells and recruit and activate 
immune cells.  However, HMGB1 is not released any time a cell dies.  Like other 
intracellular molecules that are highly immunogenic if they escape into the extracellular 
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compartment (CpG DNA and RNA are other examples), HMGB1 is only released during 
necrotic or damage-induced cell death.  During apoptotic death, HMGB1 is sequestered 
out of the reach of PRR detection.  An in vitro study used cigarette smoke to show both 
apoptotic and necrotic cell death occur post-exposure, and these results have been 
confirmed in subsequent studies (17).  HMGB1 is a DAMP widely recognized for its 
involvement in many disease processes from cancer to COPD.  Damaged cells also have 
extensive inflammasome activation (the Nalp3 inflammasome was mentioned above).  
Inflammasomes recruit cytosolic caspases, one result of which is the cleavage and 
release of IL-1beta. 
Both IL-1beta and DAMPs – the primary source being lung epithelial cells that 
bear the brunt of exposure – trigger a number of inflammatory pathways.  Resident 
leukocytes sense DAMPs via TLRs, NLRs, C-type lectin receptors, and RIG-I-like receptors 
(21).  Receptor engagement leads to signal transduction and amplification.  Pre-made 
effector molecules can be mobilized, various receptors confined to endosomes are 
circulated to the surface, cell motility is altered, and transcription factors – namely NF-
kB – turn on inflammatory genes whose products dictate the nature of the response.  
The initial response from tissue macrophages is comprised of TNF-α, IL-1, and IL-6.  
These cytokines diffuse through the interstitium to the local vasculature where they can 
begin recruiting other leukocytes.  In addition to calling in blood monocytes and 
granulocytes, these cytokines participate in feedback loops that amplify the local 
inflammatory response and induce IL-8 production.  IL-8 is a potent chemoattractant for 
neutrophils.  Research suggests that TNF-α is responsible for 70% of cigarette smoke-
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induced emphysema in a chronic exposure mouse model (22).  This is compelling 
evidence for a Th1 effector profile driving the disease process.  But TNF-α is merely a 
tool used to communicate between effector cells.  It is the effector cells themselves that 
are capable of propagating inflammation and damage. 
 
Effector Cells 
The existing body of literature on emphysema focuses on four main effector cell 
types – epithelial cells, neutrophils, monocytes/macrophages, and lymphocytes – and 
reports varying contributions, some well-established, others more controversial, of each 
cell type to the initiation and propagation of emphysema.  The evidence for each cell 
type will be discussed in turn in the following section.  Note that while eosinophils do 
play a significant role in asthma and allergy there is little evidence for their role in 
emphysema.  Eosinophilia in COPD airways is not uncommonly reported.  Clinically, 
COPD does not respond well to corticosteroids whereas patients with “eosinophilic 
COPD” who receive treatment do report improvement (23).  However, concomitant 
asthma is frequently used to explain this phenomenon.  Eosinophils will not be 
discussed further.   
 
Neutrophils 
Neutrophils or polymorphonuclear cells (PMNs) are the first responders to both 
sterile and infectious damage.  In the case of cigarette smoking, neutrophils migrate into 
the lungs in response to toxin-induced damage and oxidative stress.  Neutrophils are 
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terminally differentiated phagocytic granulocytes originating from bone marrow 
pluripotent hematopoietic cells that circulate in the blood for 6-8 hours before 
unobtrusively apoptosing (24).  However, in vitro experiments have shown that 
neutrophils can survive much longer – and retain their functionality – in the presence of 
IL-1β or LPS (25).  Despite being short-lived in nature, neutrophils are abundant, 
comprising 70% of the blood leukocyte population in adult humans and 30% in mice 
(24).  Their high numbers are maintained by the bone marrow pool and turnover is rapid 
to offset apoptotic loss.  The characteristic neutrophil granules contain antimicrobial 
peptides that are made continuously and contained within fused vesicles.  
Degranulation – the primary effector function of neutrophils – is preceded by many 
sequential activation events.  These events rely on TNF-α, IL-1, and IL-8, among other 
PAMPs and DAMPs, which are only present in the context of injury or infection.  
Neutrophil granules are kept strictly segregated from the body in the absence of these 
signals.    
The aforementioned cytokines are recognized by endothelial cells lining 
pulmonary vessels and trigger the display of adhesion molecules for recognition by 
PMNs.  PMNs circulate the blood at a high velocity.  Like other leukocytes, priming is an 
important step in activation and can alter the potency of the effector response.  
Neutrophils are primed by cytokines such as TNF-α and by hypoxia (2).  Selectin and 
integrin recognition slows these cells down as they weakly bind to blood vessel walls.  In 
the presence of the proper signals, weak interactions are exchanged for stronger ones.  
PMNs can then migrate across vessels into tissues down cytokine concentration 
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gradients to the origin of inflammation (reviewed in (24)).  Endothelial cells stimulated 
with TNF-α and IL-1 produce granulocyte-macrophage colony stimulating factor (GM-
CSF, CSF2), a cytokine that is known to activate neutrophils and potentiate the 
production of reactive oxygen species (26).  Neutralizing GM-CSF with antibody stunts 
ROS production in neutrophils by 50% to 70% (26).  This suggests that how neutrophils 
are recruited can have an impact on downstream effector function.  IL-8 (CXCL8) is a 
powerful chemoattractant that directs PMNs from the vasculature into the tissue (27).  
After CXCR1 or CXCR2 – receptors for IL-8 – are engaged and extravasation is complete, 
leukotriene B4 (LTB4), the complement fragment C5a, and DAMPs such as 
mitochondria-derived formylated peptides serve as end-stage chemoattractants (25).  




The PMN response to injury is rapid.  For example, after a mouse aspirates 
elastase, thousands of neutrophils are drawn into the lung in mere hours – their 
Figure 3: Neutrophil recruitment, extravasation, and effector functions. 
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numbers peak about 24 hours after the initial stimulus.  Depending on the intensity of 
the inciting stimulus neutrophils counts can reach into the hundreds of thousands. 
Neutrophils have a potent arsenal of effector molecules including reactive 
oxygen species (ROS’s), proteases, defensins, and antimicrobial peptides that are very 
effective against a spectrum of pathogens.  The neutrophil is a key component in the 
innate immune response against bacterial (28), viral (29), fungal (28), and parasitic (30) 
pathogens.  Neutrophil-deficient animals suffer from recurrent bacterial infections (31).  
While it is well-documented that neutrophils play an important role in the early stages 
of wound repair through the release of pro-resolving lipid mediators such as lipoxin 
A4(LXA4) and resolvins (25), the beneficial and detrimental roles that neutrophils play 
during chronic inflammation is less clear.  Because innate effector functions are by 
definition nonspecific, collateral damage to the body occurs.  During acute infection this 
collateral damage is a small price to pay.  During a chronic infection or sterile 
inflammation, this remittent damage becomes a significant source of the pathology and 
it often becomes difficult to tease apart which is the main offender.  Illustrative of this 
conundrum is the involvement of oxidative stress in tissue damage (20).  ROS’s directly 
damage tissue, provoking the release of DAMPs that in turn induce inflammatory 
cascades (20).  Neutrophils and other leukocytes can be the source of ROS’s, but more 
relevant to the discussion of emphysema, ROS’s can come directly from cigarette smoke 
(32).  Not only do smokers have a higher ROS load, they also have fewer antioxidants to 
relieve the tremendous oxidative stress (32).  Given this, it is difficult to prove that 
neutrophils release these ROS’s and proteases upon migration to the lung.  Neutrophils 
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are not the only cells to release these effector molecules; and ROS’s are degraded by 
antioxidants and proteases quickly inactivated by serum antiproteases soon after 
release.  There is to date no confirmed mechanism explaining why neutrophil elastase 
KO mice show 59% protection from emphysema (33). 
A newly characterized effector mechanism of neutrophils is the release of 
neutrophil extracellular traps (NETs), or the extracellular fibril matrices formed when 
neutrophils release their DNA and proteins.  Immunofluorescent imaging shows NETs 
are present four hours after LPS administration (21).  Following activation, neutrophils 
can release NETS in as little as ten minutes (34).  NETs work by trapping infectious 
agents, scavenging debris, and concentrating proteases and anti-microbial peptides to 
efficiently eliminate these threats with minimal damage to the host.  In a mouse model 
of sepsis, blocking NET formation reduced Escherichia coli clearance from the blood and 
resulted in greater dissemination (21).  While beneficial in the context of infection, NETs 
are negatively implicated in sterile damage.  Release of NETs is associated with IL-8 and, 
more recently, with HMGB1 through interactions involving TLR4 (35).  Recalling that 
HMGB1 is associated with necrotic death, which is in turn associated with smoking, NETs 
could very well play a role in emphysema.  Many components of NETs, such as 
extracellular histones, are antigenic and require swift degradation and clearance.  Serum 
DNases play some role in NET degradation, but twelve hours incubation with plasma 
from healthy donors is not sufficient to fully clear NETs (36).  Complement factor C1q 
enhances NET degradation by DNase (36).  Macrophages are also involved in NET 
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clearance, with eighteen hours incubation with monocyte-derived macrophages cutting 
NET activity in half (36).  The release of NETs may be rapid, but clearance is slow. 
It is also noteworthy to mention other chronic lung diseases exhibiting 
neutrophilia comparable to or more extensive than that seen in emphysema, such as 
cystic fibrosis, do not involve alveolar destruction.  Other factors must be involved.  A 
2012 review of neutrophils in COPD presents evidence that hypoxia – induced by 
smoking – alters neutrophil survival and function, delaying apoptosis and enhancing the 
release of proteases (2).  The idea that cigarette smoke might durably alter the 
phenotype of immune cells is key to understanding why lung function continues to 
decline even after smoking cessation (2).  It might also explain why patients with COPD 
struggle to clear bacterial lung infections despite their neutrophilia.  The detrimental 
effects of cigarette smoke are shared by lung macrophages.  A 2009 study published 
that cigarette smoke impaired the ability of macrophages to phagocytize apoptotic 
neutrophils (37).  This dysfunctional phagocytosis could be linked to an excess of 
neutrophil elastase, which has been shown to cleave certain complement fragments and 
receptors involved in phagocytosis (2).  In vivo mouse studies have shown apoptotic 
cells that are not promptly removed from the inflammatory environment are subject to 
secondary necrosis releasing additional DAMPs into the lung (38). 
Hoenderdos and Condliffe proposed in their 2013 review that the magnitude and 
dynamics of neutrophil transepithelial flux influence epithelial integrity (2).  This 
migration from pulmonary capillaries to the lung lumen promotes both neutrophil 
elastase-mediated epithelial cell apoptosis and β-catenin- mediated membrane repair 
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signals (39)(40).  Following the biological paradigm that balance among interdependent 
pathways is critical to maintain homeostasis and health and where imbalances exist 
disease soon follows, perhaps the influence of cigarette smoke on leukocyte function, 
apoptosis, and phagocytosis disrupts this delicate balance and leads to a chronic 
inflammatory response. 
 
Monocytes and Macrophages 
Monocytes and macrophages are derived from hematopoietic stem cells in the 
bone marrow, and the classic paradigm is of a monocyte circulating in the blood until 
being called into the tissues at which point the monocyte differentiates into a tissue 
macrophage.  These macrophages work alongside tissue resident dendritic cells and 
mast cells as sentinels, surveying the tissues and responding to damage of both sterile 
and infectious origin.  In emphysema, these macrophages are the first to release TNF-α, 
IL-1, IL-6, and IL-12 that initiate the complex cascade of inflammatory molecules – a 
crucial step in the pathologic process.   
Recent evidence contradicts that blood monocytes are the source of tissue 
resident macrophages.  In the evolving paradigm shift, macrophages are now believed 
to seed the tissues early in embryonic development, maintain themselves through local 
proliferation, and that the parent macrophage’s differentiated state is passed on to 
daughter cells (41).  Such inheritance of an effector phenotype has strong implications 
for disease – the inflammatory environment of a past illness could influence the course 
of future disease in that same organ.  In homeostasis, depleting circulating monocytes 
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has no significant effect on tissue macrophage populations (42).  Many lineage-tracing 
models found that peritoneal, alveolar, splenic, skin, mucosal and liver macrophage 
populations did not have markers of monocytic origin (41).  Of more relevance to the 
lung, 1-10% of alveolar macrophages are proliferating under steady-state conditions, 
and a “strong expansion” of alveolar macrophages was reported in response to 
diphtheria toxin and clodronate-depletion (42).  Considering GM-CSF, a cytokine growth 
factor produced by lung epithelial cells in response to cigarette smoke-induced damage, 
it would not be surprising if lung macrophage were found to proliferate in emphysema 
as well.  Most of the research investigating factors that maintain tissue macrophage 
populations has been done in disease-free models.  The extent of monocyte recruitment 
in disease states such as emphysema is unknown. 
 
 
Figure 4: Macrophages are a central regulator of the immune response to cigarette smoke. 
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Macrophages release mediators that coordinate granulocyte (particularly 
neutrophil), dendritic cell, epithelial cell, and lymphocyte responses.  The cytokine 
profile in emphysema – namely IFN-gamma, TNF-α, IL-1, IL-6, IL-12 – suggests that lung 
macrophages are classically activate (M1), a phenotype associated with NF-kB 
activation, enhanced phagocytic activity and ROS production (43).  Macrophages from 
smokers and COPD patients show increased proliferation and prolonged survival, 
mechanisms which might account for the increase in CD68+ macrophages in the 
bronchial submucosa of COPD patients (44).  In culture, alveolar macrophages harvested 
from smokers release more MMP1 (a broad-spectrum collagenase) and MMP9 
suggesting their inflammatory potential (44).  While neutrophil elastase KO mice 
showed 59% protection from emphysema (33), macrophage elastase KO mice showed a 
more impressive 100% protection from cigarette smoke-induced emphysema (45).  Such 
complete protection in the absence of macrophage elastase underscores the 
importance of these cells in initiating emphysema.  Figure 4 depicts the many reported 
roles that macrophages play as a central regulator of the immune response to cigarette 
smoke (43). 
Unlike neutrophils, macrophages localize to the site of alveolar destruction (4).  
They are present in the lung parenchyma, sputum, BAL fluid, and airways of COPD 
patients (4).  Most notably, a 2001 study compared lung resection samples from 
patients with similar smoking histories, but different degrees of emphysema, and found 
that parenchymal macrophage levels were elevated 25-fold in smokers with 
emphysema compared to smokers without emphysema (8).  This is a striking 
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observation, but the possibility that macrophages are responding to damage and not 
necessarily causing it cannot be eliminated.  Additionally, the extent of emphysema in 
resected lungs was observed to correlate with macrophage levels, but not with 
neutrophil levels (1). 
IL-18 is an IFN-gamma-inducing, proinflammatory cytokine produced by 
macrophages and associated with a Th1 phenotype.  Besides being up-regulated in 
COPD patients compared to healthy smokers and nonsmokers, studies in mice have 
demonstrated IL-18 is important in the disease process (19).  IL-18R KO mice show 
decreased inflammation and a 51.5% reduction in emphysema as measured by alveolar 
chord length (46).  IL-18 in conjunction with IL-12 activates CD8+ T cells and 
correspondingly cell-mediated immunity.  Elevated CD8+ T cell counts are commonly 
reported in emphysematous lungs, more so than any other lymphocyte population, and 
in fact continue to rise as the disease progresses (19).  The repercussions of this will be 
considered when autoimmunity as a potentiator of emphysema is discussed. 
A possible connection between dysfunctional macrophages and chronic 
inflammation is the previously discussed NET, or neutrophil extracellular trap.  A recent 
publication claims that physiological amounts of DNase I – a key enzyme in the cleanup 
of chromatin released from necrotic cells – are not sufficient to fully degrade NETs (36).  
Macrophages are proposed to engulf and silently clear NETs from the extracellular 
environment; however, recall that cigarette smoke impairs phagocytosis in 
macrophages potentially allowing NETs to persist in an environment where antigen 
surveillance, presentation and recognition are ongoing.  The proteins and DNA that 
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make up NETs are normally intracellular and if recognized by the adaptive immune 
system could result in autoimmune activation and disease.  In fact, a subset of patients 
with systemic lupus erythematosus (SLE) – regarded as the prototype autoimmune 
disease – have impaired degradation of NETs and anti-nuclear autoantibodies (25).  
Autoantibodies to dsDNA or histones are features of many autoimmune diseases, and if 




In the past decade or two, a new mechanism for emphysema was proposed that 
argues adaptive immunity and not an innate protease imbalance is the primary driver of 
emphysema.  Beginning with The Lung Health Study – a first-of-its-kind, longitudinal 
study following 5,000+ smokers over eleven years – the observation was made that 
between 8-10% of former smokers were still experiencing a decline in lung function (3).  
Removing the insulting stimulus did not stabilize their condition.  This was suspiciously 
similar to the behavior of autoimmune diseases where immunologic memory and ever-
present self-antigens lead to a chronic, difficult to treat condition.  Around the same 
time when The Lung Health Study data was being compiled, another lab published that 
CD8+ T cells had an elevated presence in smoker lungs (3).  These two findings sparked a 




The evidence for autoreactive antibodies – i.e. anti-epithelial and anti-elastin – in 
emphysema patients is scarce, and what exists is often contradictory, but conversely 
studying autoreactive antibodies is inherently more difficult than studying autoreactive 
T cells (3).  The extent of B cell infiltration in the airways does correlate with the severity 
of COPD, as demonstrated in resected lung tissue from patients classified by Global 
Initiative for Chronic Obstructive Lung Disease (GOLD) standards (47).  Additionally, the 
progression to severe and very severe COPD is associated with an increase in airway 
lymphoid follicles, which are structurally important for B cell activation, selection, and 
antibody production (43).  However, exacerbations triggered by opportunistic infection 
as the integrity of the pulmonary epithelial barrier fails are also associated with severe 
COPD.  Infection and not autoimmunity could be driving the organization of lymphoid 
follicles in the lung.  Any verdict on B cell involvement would be premature, so T 
lymphocytes and cell-mediated immunity will be the primary focus of this section. 
When emphysema does not resolve or stabilize in former smokers, what 
continues to trigger the release of MMPs and elastase?  IFN-gamma indirectly induces 
the elastin-degrading MMP12 (48).  IL-17A indirectly induces neutrophil and dendritic 
cell chemoattractants and MMP12 (49).  IFN-gamma is the signature cytokine of the Th1 
subset of CD4+ T cells, and IL-17A is characteristic of Th17 cells.  No Th2 markers are 
evident.  T-regulatory cell counts are also markedly low, translating to low levels of IL-10 
and only limited immunomodulatory mechanisms to counter the extensive 
inflammation (19).  Indeed, T cells isolated from emphysematous lungs are largely Th1 
(4), and lung myeloid dendritic cells isolated from emphysematous lungs have been 
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shown to induce IFN-gamma and IL-17A secretion from CD4+ T cells in vitro (49).  There 
is also a positive correlation between the degree of alveolar destruction, the severity of 
clinical symptoms, and the number of T cells (4).  Importantly, the combination of Th1 
and Th17 cells has been experimentally linked to many autoimmune diseases in humans 
(3). 
This body of evidence is only meaningful if T cells are present and activated in 
emphysematous lungs – no adaptive effector functions can take place without 
recognition of a specific antigen, and in the case of the autoimmunity hypothesis, a 
specific self-antigen.  Early studies have demonstrated that smokers have increased 
numbers of dendritic cells in airway and alveolar walls, providing a mechanism for 
antigen presentation and T cell activation (4).  Activated CD4+ T cells have themselves 
been quantified and found elevated in the airway walls of COPD patients (44).  A 2007 
publication presented evidence that peripheral blood CD4+ T cells isolated from 
emphysema patients produced significant levels of IFN-gamma and IL-10 in response to 
treatment with elastin, but not collagen or albumin; a response that was attenuated 
when MHC II molecules were blocked (50).  Control subjects did not respond to elastin, 
collagen, or albumin.  Furthermore, the IFN-gamma response was found to positively 
correlate with the severity of emphysema.  Plasma samples from study volunteers were 
also screened for autoreactive antibodies and anti-elastin antibodies were found to be 
significantly elevated in emphysema patients but not controls.  Again, this report of an 
autoreactive humoral response should be considered alongside similar studies that did 
not detect a significant difference between patients and controls.  The opinion 
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presented in a 2012 review by Kheradmand and colleagues was that differences in 
antibody testing rigor and inclusion criteria and stratification of study participants 
account for these differences (3).  In a similar demonstration of the destructive potential 
of autoreactive CD4+ T cells, mice who received adoptive transfers of pathogenic CD4+ 
cells developed emphysema in the absence of any other stimuli (51).  The same study 
showed that mice inoculated intraperitoneally (IP) with xenogeneic epithelial cells also 
develop emphysema (51).   
CD8+ T cells exact direct damage on cells when activated through the release of 
cytotoxic mediators such as perforin and granzymes.  CD8+ T cell activity is evident in 
sputum and BAL fluid of smokers – both perforin and granzyme B are elevated (44).  
These enzymes trigger caspase-mediated apoptosis, and indeed there is a positive 
association between the number of CD8+ cells and the number of apoptotic cells in 
alveolar walls (44).  CD8+ T cells isolated from the sputum of COPD patients 
demonstrate increased perforin expression and cytotoxic activity (44).  In 2007, a study 
published that CD8 KO mice smoked twice daily for six months did not develop 
emphysema and showed only limited inflammation compared to their wild-type (WT) 
and CD4 KO comparators (52).  Both WT and CD4 KO mice developed emphysema.  This 
phenomenon was attributed to IFN-gamma-inducible protein-10, a CD8+ T cell product 
that induces MMP12.  It is suspicious that CD4 KO mice still developed emphysema 
because if blocking the CD8 response is protective as the article suggests, and knowing 
that CD4+ T cells prime CD8 effector function, it would be expected that CD4 KO’s would 
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also show some protection from emphysema.  Regardless, the authors concluded that 
CD8 T cells were required for alveolar destruction in cigarette-smoked mice. 
The literature does not agree on a conclusive role for lymphocytes in 
emphysema, clearly illustrated by experiments with RAG1 KO mice that lack both T and 
B cells – these mice still develop smoke-induced emphysema after six months of 
exposure (53).  The RAG1 KO experiments were done in BALB/c mice; the CD8+ KO 
experiments used C57BL/6 mice – a confounding variable that could explain the 
outcomes to a common research question.  The reality of models is that they are 
imperfect.  Lymphocytes may not be necessary for the development of emphysema in 
either humans or mice, or this could be a point at which the pathogenesis in the model 
diverges from the pathogenesis in humans.  On that note, alveolar damage in smoked 
mice does resolve after smoking cessation, whereas in humans this is clearly not the 
case, putting the validity of the cigarette smoke model in question (3). 
 
Epithelial Cells 
Airway epithelial cells experience the brunt of the damage from cigarette smoke 
and other inhaled environmental irritants.  These cells are effective mediators of the 
barrier function between the body and the outside world – they secrete mucus, 
antimicrobial peptides, antioxidants, antiproteases, and transport IgA into the lung 
lumen (4).  However when damaged, epithelial cells release DAMPs and alarmins into 
the lung parenchyma that are recognized by resident macrophages and innate lymphoid 
cells.  In response to cigarette smoke and the resulting oxidative stress epithelial cells 
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secrete inflammatory mediators such as TNF-α, IL-1β, GM-CSF, and IL-8 (4).  While 
epithelial cells are not classically considered immune cells, their role in the inflammatory 
process cannot be overlooked.  Epithelial cells account for 16% of all cells in the lung, 
which is more than double the maximum estimates for alveolar macrophages (54). 
An upregulation of pro-apoptotic and various antioxidant genes is seen in 
smoker lung epithelium (44).  Epithelial cells also upregulate proteins that fight ROS 
damage – namely unfolded protein response (UPR) proteins – in association with 
chronic smoking (44).  From a chronic care perspective, growth factors are a particularly 
troubling aspect of the epithelial response to cigarette smoke.  An irreversible activation 
of the epidermal growth factor receptor (EGFR) cascade occurs in smokers, and 
overexpression EGFR is associated with the development of lung cancer (44). 
Overexpression, predominantly in epithelial cells, of the receptor for advanced 
glycation end products (RAGE) was observed in smoker lungs with emphysema but not 
in healthy smokers and nonsmokers (55).  RAGE interacts with extracellular HMGB1 – a 
highly immunogenic intracellular protein released from damaged and necrotic cells that 
was previously discussed.  Overexpression of RAGE was associated clinically with a 
decline in lung function, and on a molecular level with an increase in oxidants (NO), a 
decrease in antioxidants (glutathione), and an increase in NF-kB-dependent 
proinflammatory cytokines (55).  The lab then confirmed these results could be reversed 
with pretreatment with anti-RAGE antibody.  It is presently unknown whether RAGE 




From the above discussion on effector cells it is easy to see how epithelial 
damage can lead to inflammation, which in turn can lead to more damage and more 
inflammation, and so the vicious chronic cycle is established.  This is where some 
immunologists propose the adaptive immune system comes in, escalating a simple 
condition of chronic inflammation to one that extinguishes any hope of resolution – 
autoimmunity.  As previously discussed, persistent tissue damage allows intracellular or 
modified extracellular fragments to accumulate and mingle with antigen-presenting 
cells (APCs) and lymphocytes.  These fragments are not recognized by the adaptive 
immune system – it has not been tolerized to them – and thus autoimmunity can result.  
There is substantial evidence suggesting emphysema is instigated by innate immune 
mechanisms but that the adaptive mechanisms – cytotoxicity and antibody – help 
perpetuate the disease.  Even so, if innate mechanisms start the disease process they 
are a possible point of intervention and deserving of further investigation. 
 
The Elastase Model of Emphysema 
The complex etiology of emphysema and COPD mandates the use of in vivo 
animal models; rodents, guinea pigs, dogs, and monkeys, to name a few.  Mice are by 
far the animal of choice and not surprisingly so considering their biology is well defined, 
they can be genetically engineered, a wide array of antibody reagents are available, and 
they are relatively affordable.   
In mice, emphysema can be induced with particulates (cigarette-smoke extract, 
silica), proteases (elastase), oxidants, cigarette smoke, and certain genetic mutations.  
28 
 
Cigarette smoke might seem the intuitive choice given that smoking is the primary cause 
of emphysema in people.  However, mice exposed to cigarette smoke take many 
months before emphysematous changes become manifest, a costly limitation, and the 
emphysema is mild even when the exposure is high (56).  The cigarette smoke model 
also does nothing to tease apart the epithelial damage-driven, immune-mediated 
pathology from the direct effects of cigarette smoke-induced oxidative stress.  In 
contrast, emphysema in the elastase model is dose-dependent ranging from mild to 
severe depending on the number of enzymatic units administered.  An inexpensive, 
single dose of elastase is enough to cause emphysema in mere weeks.  The direct 
oxidative effects of cigarette smoke have no influence in the elastase model, allowing 
emphysema as a disease of immune dysregulation to be studied with fewer 
confounders.  But the elastase model comes with its caveats.  Some evidence suggests 
elastase-induced emphysema diverges mechanistically from cigarette smoke-induced 
emphysema, which makes for a convoluted extrapolation from mice to people.  While 
symptoms of systemic disease are evident in clinical emphysema as well as both the 
elastase and cigarette smoke murine models, emphysema progresses in people over 
time even after smoking cessation.  Quite the opposite of progression, lesion resolution 
is seen in the cigarette smoke model.  Elastase-induced emphysema shows lesion 
maintenance with evidence of progression being questionable (56).  Moreover, is it valid 
to study a disease of chronic environmental exposure using a single-insult, acute model?  
Emphysema is not the only chronic disease facing this research discrepancy.  In fact, as 
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today’s sphere of public health becomes predominated by chronic diseases this is fast 
becoming the ultimate question of modern medical research. 
The parameters of study for emphysema are alveolar destruction and reduction 
in ventilation and gas exchange; they have been defined from the clinical criteria.  
Historically, mean airspace chord length (Lm) has been the measurement of choice for 
alveolar destruction.  Mean airspace lengths, or the average distance between luminal 
walls, are obtained by random sampling of H&E stained lung histology sections.  
Emphysema is marked by large chord lengths because the alveolar septa dividing up the 
airspace and increasing the surface area for gas exchange are greatly reduced in 
number.  However, this approach is not perfect and has received criticism from experts 
in the field.  The main criticisms are, 1) Lm cannot distinguish between tissue distension 
– from over-inflation or loss of elasticity – and tissues destruction, 2) random sampling 
does not take into account the anisotropy of emphysema, and 3) Lm does not always 
predict lung function deficits.  A 2008 article by W. Mitzner argues that Lm is still useful 
and taking into account lung volume, sampling 10,000 or more chord lengths, and 
measuring Lm in conjunction with lung function allows researchers to avoid these pitfalls 
(57). 
Reductions in ventilation and gas exchange can be quantified by a variety of tests 
for lung function.  Diffusion coefficients are a standard measure of gas exchange 
capacity, which would be impaired anytime the surface area for gas exchange was 
compromised.  For such tests, a highly soluble gas (carbon monoxide) and insoluble gas 
(neon) are inhaled at known concentrations and expired air is analyzed for changes in 
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concentrations.  Additionally, forced expiratory volume (FEV1), total lung capacity (TLC), 
functional residual capacity (FRC), and residual volume (RV) are all clinically accepted 
and useful in grading COPD severity.  These and other tests of lung function are 
reviewed in “Outcome measures in chronic obstructive pulmonary disease (COPD): 
strengths and limitations” by Glaab, Vogelmeier, and Buhl (58). 
 
Hypothesis and Justification 
The purpose of this research is to directly assess the role – be it protective, 
detrimental, or neutral – that neutrophils play in the development of IT elastase-
induced emphysema.  Lung histology and function will be the primary methods of 
emphysema assessment in our 21-day, elastase- BALB/c mouse model, and neutrophil 
involvement will be determined by comparing these parameters in neutrophil-intact and 
neutrophil-depleted mice.  Because neutrophils are characteristically the first 
responders to damage or infection we intend to follow the acute BAL cellular response 
to IT elastase and more precisely define the window of neutrophil activity in the lung.  
The major effector cell types – neutrophils, macrophages, and lymphocytes – will be 
followed over various early time points in the BAL fluid of elastase-treated mice.  Using 
this data we will target our antibody depletion of neutrophils during their frame of 
influx and track changes in other cell types associated with depletion. 
We hypothesize that neutrophil depletion will worsen the elastase-induced 
emphysema pathophysiology – that neutrophils will be found to be protective.  We 
choose this stance for many reasons.   
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Neutrophils are important in tissue remodeling and repair, and they have in their 
arsenal of effector mechanisms the newly discovered NET which has not been 
characterized in models of sterile injury.  Some studies have shown PMNs to be 
beneficial in colitis (reviewed in (59)), a chronic inflammatory disease of the GI tract, but 
such evidence is limited in the context of the lung.   
Glucocorticoids inhibit neutrophil adhesion to vascular endothelium and limit 
transmigration into the parenchyma (21).  It has been mentioned that glucocorticoids 
are ineffective in treating COPD.  This suggests that neutrophil recruitment is not 
significantly involved in the maintenance of disease in emphysema.   
A 2013 review by Kolaczkowska and Kubes presented the idea of separate but 
inducible inflammatory and anti-inflammatory neutrophil states (21).  Lipoxin A4 (LXA4) 
is a steroid associated with the resolution of inflammation and it has been shown to act 
on neutrophils, inhibiting neutrophil migration and recruiting macrophages to clear 
apoptotic neutrophils (21).  In COPD patients, serum amyloid A (SAA), an inflammatory 
lipoprotein opposing the action of LXA4, is elevated and LXA4 is disproportionately low 
compared to healthy controls (60).  Furthermore, the same lab showed that SAA 
correlates with IL-8, neutrophil recruitment and granule release (60).  Perhaps low LXA4 
prevents neutrophils from adopting an anti-inflammatory phenotype in the context of 
emphysema. 
Arginase I is a component of neutrophilic granules that has been found to inhibit 
T cell activation (21).  It has been proposed that autoimmunity continues to drive 
emphysmatous changes even after smoking cessation (3).  Depleting neutrophils could 
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have an impact on the magnitude of the T cell response and thus increase the risk of 
developing autoimmunity, especially in habitual smokers whose lungs are chronically 
producing DAMPs in response to noxious stimuli.  Conversely, neutrophil-derived 
chemokines CCL2, CXCL9 and CXCL10 help recruit TH1 and TH17 cells to sites of 
inflammation (25). 
A 1999 article published that neutrophil antibody depletion did not protect rats 
from developing emphysema in a cigarette-smoke model, but mean airspace chord 
lengths and immunologic assays for elastin fragments in lavage fluid found 
monocyte/macrophage depletion was protective (61).  In contrast, a 2003 study showed 
that neutrophil elastase KO mice were 60% protected from cigarette smoke-induced 
emphysema (33).  The length of smoke exposure was different (two versus six months), 
the method of depletion different (once-weekly administration of antibody targeting 
neutrophils versus genetic knockout of neutrophil effector function), and the animal 
model was different (rat versus mouse).  Given two very different study designs, it is 
hardly surprising the results do not agree; but perhaps a discovery is hiding in their 
differences.  Neutrophil elastase KO mice had fewer recruited neutrophils, fewer 
recruited monocytes, less macrophage elastase, and smaller airspaces.  In both 
experiments reduced recruitment of monocytes was associated with protection.  
Summarizing these two studies we find that removing neutrophils and neutrophil 
elastase does not protect against emphysema, but removing only the elastase does 
protect.  Perhaps too much emphasis is placed on neutrophil elastase and too little on 
other neutrophil products. 
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While the role of neutrophils in emphysema has been previously tested, no work 
has been done in the elastase model and varying reports exist for the cigarette smoke 
model.  Beyond expanding our understanding of the elastase model, the original 
research presented in the subsequent sections will shed additional light on an unsettled 





MATERIALS AND METHODS 
Mice 
BALB/c and C57BL/6 male mice, 6-8 weeks of age, were obtained from The 
Jackson Laboratory (Bar Harbor, ME, USA).  All mice were bred and housed within 
barrier filter-top cages, provided food and water ad libitum, and exposed to a 12-hour 
light/dark cycle.  All animal procedures performed in this study were approved by the 
Johns Hopkins Animal Care and Use Committee (Baltimore, MD, USA), and were in 
accordance with the National Research Council’s Guide for the Care and Use of 
Laboratory Animals federal guidelines.  Within experiments mice were age-matched; 
between experiments slightly different ages were used depending on availability but the 
range was limited to 7-12 weeks. 
 
Elastase Administration 
Mice were challenged via intra-tracheal (IT) aspiration with three enzymatic units 
(U) of porcine pancreatic elastase (PPE).  Mice were first anesthetized with a mixture of 
1.75 mL isoflurane and 3.25 mL propylene glycol.  A piece of cotton gauze was soaked 
with the 5 mL isoflurane mixture and placed at the bottom of a bell jar.  A mouse was 
then enclosed in the bell jar and monitored until its breathing rate had slowed to 
approximately one breath per second and this rate was maintained for about ten 
breaths.  At this point, the mouse was considered properly anesthetized, removed from 
the chamber and placed on its back at a forty-five degree incline.  Forceps were used to 
gently extend and stabilize the tongue.  Using a pipet, 50 µL of phosphate buffered 
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saline (PBS) containing 3 U of PPE was placed at the back of the throat.  A gloved finger 
was used to cover the mouse’s nose, forcing the mouse to inhale through the mouth 
and aspirate the PPE into the lungs.  Successful aspiration was presumed when the 
mouse had taken a few breaths – evidenced by expansion of the chest cavity – and the 
oropharynx appeared void of PPE solution. 
PPE-treated mice were returned to their cages and monitored for various lengths 
of time during which they were provided food and water ad libitum. 
 
Bronchoalveolar Lavage (BAL) 
To perform BAL, a 450 mg/kg dose of avertin – diluted from stock in 10% sodium 
chloride solution – was injected IP to anesthetize the mice.  The anesthetized mouse 
was verified unresponsive to tactile stimulation and the surface of the mouse was 
treated with a 70% ethanol solution to reduce the possibility of microbial 
contamination.  An incision was made along the ventral midline and blunt dissection 
used to free the trachea.  A 5 mm incision was made in the midline of the trachea and a 
lavage tube (cannula) was inserted into the trachea and stabilized with 10-0 silk suture 
material.  The end of the cannula outside the trachea contained a luer lock for the 
attachment of a syringe.  PBS (1X, 4˚C) was introduced into the lung via the cannula to 
wash the lung three times – 800 µL for the first wash, and 600 µL for the second and 
third wash.  The recovered lavage volumes were stored on ice, pooled, the total volume 
measured, and spun down at 1500 rpm for 6 minutes at 4˚C.  The supernatant was 
removed, cells suspended in 2 mL ACK lysing buffer (Quality Biological, INC.), incubated 
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at room temperature for 5 minutes, and then diluted in another 2 mL volume of cold 
PBS before a second round of centrifugation.  (Occasionally two washes with ACK buffer 
were required to lyse all erythrocytes in bloodier BALs.)  The supernatant was removed 
and the cells suspended in 1 mL 4˚C PBS and stored on ice.  The number of cells in the 
BAL was evaluated using light microscopy and a hemacytometer (Hausser Scientific) and 
the data were expressed as the number of cells per mL of recovered BAL fluid.  To 
obtain differential counts, the cells were diluted to 100,000 cells/-mL and 1 mL was 
adhered to a glass slide with the aid of cytology funnels (Fisher Scientific) and a 
cytocentrifuge (CytoSpin, Shandon).  Cells were subsequently fixed and stained utilizing 
Diff-Quik® (Andwin Scientific) and enumerated using light microscopy. 
 
Hemoglobin Assay of BAL Fluid 
A hemoglobin assay was used to estimate the quantity of blood that was 
collected in the BAL.  100 µL of ACK lysing buffer was added to 100 µL of BAL fluid, 
allowed to sit at room temperature for 5 minutes, centrifuged at 4˚C for 6 minutes at 
1500 rpm, and 100 µL of supernatant was loaded into a microtiter plate.  Absorbance 
readings at 405 nm were collected using a spectrophotometer (Molecular Devices, LLC).  
The 1:1 dilution of BAL with ACK buffer was performed to avoid spectrophotometer 






 Whole lungs were weighed immediately after resection (wet weight) at 1, 3, and 
5 days post-PPE.  Subsequently they were dried in a 65˚ C incubator for 72 hours and 
again weighed (dry weight).  Wet weights, dry weights, and wet-to-dry ratios were used 




Mice were anesthetized with avertin and the trachea was exposed and 
cannulated as described above.  Z-Fix® (Anatech LTD.) was introduced down the cannula 
at a constant pressure of 30 cm of water for 3 minutes.  Fixed lungs were then carefully 
dissected out of the body cavity to prevent perforation and stored in conical centrifuge 
tubes containing 35 mL of Z-Fix® for 48 hours before further processing.  Random, 2-3 
mm square pieces were cut from fixed lungs and imbedded in paraffin blocks.  From 
these blocks five micron sections were cut and stained with hematoxylin and eosin 
(H&E) for light microscopy and imaging.  Lung sections were analyzed to measure the 
extent of emphysema using the mean airspace chord lengths (Lm) based on calculations 
described by Knudson and colleagues (62).  Lm was calculated using parenchymal 
volume and alveolar surface area measurements, being directly proportional to volume 





Lung Function Analysis 
Total Lung Capacity (TLC) 
A cannula was inserted into the trachea of anesthetized mice and connected to a 
constant-flow ventilator.  Following a deep inspiration to 30 cmH2O for five seconds, the 
mouse was returned to normal ventilation – tidal volume of 0.2 mL of 100% O2 at a rate 
of 150 breaths per minute – before degassing of the lungs for 3 minutes.  A previously 
described method for generating quasi-static pressure-volume curves was utilized after 
degassing (63).  To summarize, two sequential airway P-V loops were acquired by the 
PowerLab digital data-acquisition system beginning at a pressure of 0 cmH2O and ending 
with a maximum pressure of 35 cmH2O.  The volume corresponding to a pressure of 35 
cmH2O was defined as TLC.  TLC is a useful parameter for detecting emphysematous 
physiology; high TLC values indicate destruction of lung architecture.     
    
Diffusion Factor of the Lung for Carbon Monoxide (DFCO) 
Anesthetized, intubated mice were assessed for the extent to which carbon 
monoxide (CO) diffused from inspired air into the lung parenchyma in relation to an 
insoluble comparator, neon (Ne).  At a constant pressure and volume, diffusion of CO is 
dependent on alveolar SA, alveolar thickness, blood flow to pulmonary capillaries, and 
the rate of chemical binding to hemoglobin (64).  DFCO, as previously described (REF), 
involves four gas chromatograph (GC) measurements: concentration of CO in the 
calibration gas, concentration of CO in the inspired gas, concentration of Ne in the 
calibration gas, and concentration of Ne in the inspired gas (64).  0.8 mL of calibration 
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gas – approximately 0.5% CO and 0.5% Ne in composition – is injected using a syringe to 
inflate the lung, and after 9 seconds the gas is withdrawn, diluted to 2 mL with room air, 
and analyzed using a GC.  When the concentration of CO in the inspired gas is low 
compared to the calibration gas, the diffusion factor is high, and vice versa.  An 




To deplete neutrophils, 500 µg of the Ly6-G-specific antibody clone 1A8 (Bio X 
Cell, Catalog#: BE0075-1) was administered IP 24 hours prior to IT challenge with 3 U of 
PPE.  To assess the extent and dynamics of neutrophil depletion in the peripheral blood, 
tail vein blood samples were taken at days -1, 0, 1, 2, 3, 5, 7, and 9 from mice in two 
experimental groups (n=2).  Both groups received antibody on day -1.  To determine if 
PPE had an effect on antibody depletion, one group received PPE on day 0 and the other 
group received an equivalent volume of PBS.  Each blood sample was diluted in 1 mL 
cold PBS and processed for differential cell counts as outlined above for BAL samples.  
Additionally, to compare neutrophils in the peripheral blood of 1A8-treated and 
elastase-only treated mice tail vein blood samples were taken at days -1, 0, 1, 2, 3, 4, 
and 5.  Three mice were randomly assigned to receive 1A8 on day -1 and another three 
mice received a PBS injection of equivalent volume also on day -1.  All mice received PPE 
on day 0. 
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To analyze the effects of neutrophil depletion on BAL cell dynamics, antibody or 
PBS was injected at day -1, PPE administered at day 0, and BAL samples were collected 
at days 1, 3, and 5 (n=3).  To analyze the effects of neutrophil depletion on lung 
histology, antibody or PBS was injected at day -1, PPE administered at day 0, and lungs 
were harvested at days 1, 3, 5, and 21 for processing.  Histology was repeated four 
times – once as a stand-alone experiment (n=3) and three times after first performing 
pulmonary function tests. 
To further characterize the effects of depletion, mice were administered 
antibody or PBS, dosed with PPE 24 hours later, incubated 21 days, after which various 
parameters of pulmonary function – namely TLC and DFCO – were measured.  Pulmonary 
function testing was performed on three occasions. 
 
Statistical Analysis 
 Graphpad Prism 4.0a  was used for all statistical analysis.  An unpaired, two-





Neutrophil-Intact Response to Elastase Challenge 
 In the mouse elastase model elastase is administered intratracheally (IT) and is 
aspirated into the lungs where it presumably exerts its main effect by degrading the 
elastin component of the extracellular matrix causing a disruption in lung epithelial cell 
organization and function, which in turn results in a breach of barrier integrity, 
hemorrhage, and an influx of inflammatory cells.  Disruption of this barrier has 
immediate effects and triggers an acute innate inflammatory response.  This acute 
phase, while measurable and important, only sets the stage for emphysema to develop 
later – weeks after the initial elastase insult.  We first sought to define this acute phase.  
BAL fluid collected from washing the lung lumen with buffered saline contains cells that 
reflect the inflammatory state of the lung and is useful for our analyses. 
 
Comparing C57BL/6 and BALB/c Mice 
Bronchoalveolar lavage (BAL) cell dynamics in response to IT elastase had been 
previously followed over five days in C57BL/6 mice.  Recently, it was determined that 
BALB/c mice produced a more pronounced and recognizable emphysema phenotype 
compared to C57BL/6 mice.  In addition, the increased sensitivity of the BALB/c strain 
required an adjustment to the amount of elastase administered from 6U to 3U in order 
to produce the appropriate level of emphysema.  Since there were no data available on 
BALB/c mice challenged with 3U of elastase, experiments were designed to define the 
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cellular dynamics in the lungs.  The experiment was designed to compare BAL cell 













In general, the cellular dynamics of the BALs from BALB/c and C57BL/6 mice 
were comparable (Figure 5a).  A notable difference was the more rapid and higher 
neutrophil influx in C57BL/6 mice as compared to the slower and smaller BALB/c influx 
within the first few hours after elastase administration.  At later time points, the 
neutrophil numbers and kinetics were essentially the same between the two strains.  
Stained cytospin preparations of cells isolated in the BAL at 24 hours post-elastase 
showed neutrophils, monocytes, and macrophages with standard morphology (Figure 
5b). 
Figure 5: (a) C57BL/6 and BALB/c mice have similar BAL cell dynamics in response to IT elastase.  BAL was 
collected at 1, 6, 12, 24, 48, 72, 96, and 120 hours post-PPE, and each point represents the average of three 
mice. (b) Representative image of BAL-derived macrophages*, monocytes
O
, and neutrophils‡ obtained 







It was concluded that the cellular dynamics in response to elastase 
administration was not significantly different between BALB/c and C57BL/6.   All 
proceeding experiments utilized BALB/c mice. 
 
Cell Dynamics – Characterizing the BAL Fluid 
Repeated measures of the BAL cell dynamics in BALB/c mice in response to 
elastase challenge were recorded over a five day period (Figure 6) and served as a useful 















Figure 6: BAL cellular profile in BALB/c mice at 1, 6, 12, 24, 48, 72, 96, and 120 hours post-PPE. Neutrophils, 
macrophages, lymphocytes, and total cells were counted for every BAL sample and each point represents 




At baseline, an average of 793 neutrophils were present in the BAL (range: 0 – 
1938) (SEM: 345).  The infiltration of neutrophils into the lungs 1 hour after PPE 
administration was significant (p = 0.0497), with counts rising to 21,480 neutrophils 
(range: 0 – 57,267) (SEM: 9,263).  Neutrophils peaked at 24 hours post-PPE at an 
average of 298,530 cells (range: 47,075 – 532,904) (SEM: 94,804).  At their peak, 
neutrophils comprised 24.97% of all BAL cells.  Neutrophils began to decline at 48 hours, 
and returned to near pre-challenge levels by 120 hours.  (Figure 6) 
 
Macrophage and Monocyte Dynamics 
At baseline, an average of 16,080 mononuclear cells were present in the BAL 
(range: 9,614 – 21,563) (SEM: 1,748).  An unexplained spike in macrophages was seen at 
1 hour post-PPE, but this spike was not significant and is likely due to sampling artifact, 
reflected in the large standard error at this time point (SEM: 582,300).  While no 
significant differences were found between adjacent time points, the general trend 
suggests that mononuclear cells do increase in the lung lumen in response to IT elastase, 
plateau after 48 hours (887,134 macrophages, or 49% of BAL cells), and by 120 hours 
their numbers still hold relatively steady (767,913 macrophages, or 50% of BAL cells) 
(Figure 6).  Variation between mice is responsible for the lack of statistically significant 
difference, and is a recurring theme in many of the cell dynamics results. 
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Lung mononuclear cell dynamics are very different from neutrophil dynamics.  
Their influx is not only delayed but also substantial – macrophages and monocytes make 
up the largest fraction of the BAL cellular response to IT elastase.   
 
Lymphocyte Dynamics 
Lymphocytes made up a small percentage of BAL cells at any given time point 
(Figure 6).  The jump in lymphocytes observed at 48 hours and subsequent plateau, 
while not statistically significant (p = 0.1804), does parallel macrophage dynamics.  
Additionally, the increase in lymphocytes from baseline to 1 hour post-PPE was not 
significant (p = 0.0795) and is likely due to blood leaking into the lumen.   
 
Total Cell Count Dynamics 
Without elastase, an average of 85,000 cells are recovered from BAL fluid (range: 
65,000 – 115,000) (SEM: 8,165).  1 hour post-PPE this number jumps to over 2.25 x 106 
cells, albeit the standard error associated with this number is enormous (SEM: 
1,134,760).  This suggests one of two things: the variability between mice is huge, or the 
method of quantifying cells is unreliable.  BAL samples collected at 12, 24, 96, and 120 
hours post-PPE had significantly more cells compared to baseline, but at 1, 6, 48, and 72 
hours cells were not significantly elevated compared to baseline.  This speaks more to 
the variation between mice at a given time point rather than being a true descriptor of 
post-PPE cell dynamics.  The trend towards elevated total cell counts is evident at all 
acute time points post-PPE (Figure 6).  
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Blood in the BAL 
Blood in the BAL fluid is evidence of lung damage, and thus is useful for 
characterizing animal dosing, assessing PPE activity, indirectly measuring the extent and 
duration of epithelial and endothelial cell damage, and estimating the time scale for 
acute resolution.  Hemoglobin is evident in the BAL fluid as early as 1 hour post-PPE 
(Figure 7).  Without an elastase insult, an average absorbance of 0.115 was recorded 
(n=6) (range: 0.110 – 0.123) (SEM: 0.002).  Absorbance at 405 nm was significantly 
elevated compared to baseline in samples from all time points post-PPE, proving the 
potency of our enzyme.  Parallel to the influx of neutrophils, blood in the BAL peaked 
between 24 and 48 hours after which it progressively declines.  An interesting 
observation was that while variation did exist between mice, later time points exhibited 











Figure 7:  
Absorbance at 405 
nm was used as a 
marker for 
hemoglobin in BAL 
samples taken at 1, 
6, 12, 24, 48, 72, 96, 
and 120 hours.  
Each point 
represents the 










Lung Histology – Defining the Extent of Alveolar Destruction 
Lung histology was examined at 0, 1, 3, and 5 days post-PPE, and upon gross 
inspection intense hemorrhage was observed on day 1 (Figure 8a).  Hemorrhage was 
less evident on day 3 (Figure 8b) and undetectable by day 5 (Figure 8c) post-PPE.  The 1, 
3, and 5 day post-PPE pattern for lung hemorrhage seen in histology sections is also 
reflected in the 405 absorbance of BAL samples (Figure 7).  Histology offers direct 
evidence of the injury response in the context of alveolar architecture.  No 
quantification of lung damage was done for these histology sections as emphysema 
cannot be measured at acute time points. 
 
 
Figure 8: H&E stained lung histology 
sections at 1 (a), 3 (b), and 5 (c) days post-
PPE viewed with a 10X objective lens.  
Note the leukocytes in the airspace, the 
parenchymal edema, and capillary leakage 
visible on day 1, reduced on day 3, and 





Neutrophil-Depleted Response to Elastase Challenge 
 After measuring the acute dynamics of cells and blood in the BAL fluid after 
elastase challenge, the next aim was to deplete neutrophils during their active window 
and look to see how this affected the development of emphysema.  Emphysema is a 
chronic disease and mice in these experiments require longer incubation post-PPE.  In 
the elastase model of emphysema, 21 days is sufficient time to see emphysematous 
changes in lung histology sections, and because lung physiology is a reporter of lung 
architecture 21 days is also suitable for measuring lung function.   
 
Systemic Depletion of Neutrophils – Action of 1A8 Antibody 
 The first task was to verify that 1A8 was both specific and effective in depleting 
neutrophils, and to identify its length of action when administered by IP injection. 
`In the peripheral blood, neutrophils were successfully and significantly depleted in 1A8-
treated mice 24 hours after antibody injection compared to controls (p = 0.0004) (Figure 
9).  In elastase-only treated mice, the neutrophil fraction was maintained at a relatively 
constant 24% of blood leukocytes throughout the six day period.  However, blood taken 
1 day after 1A8 antibody administration was virtually devoid of neutrophils and this 
depletion persisted 6 days after antibody was administered, or 5 days post-PPE, at 
which point we ceased sampling.  Evidence of rebound was observed but the 



























Figure 9:  A single 500 µg dose of 1A8 antibody injected IP 24 hours prior to elastase administration is 
enough to sufficiently deplete neutrophils for days in the peripheral blood. 16 µL of tail vein blood was 
taken from each mouse at days -1, 0, 1, 2, 3, 4, and 5 post-PPE.  Each point represents the average of three 
mice.  At all time points after 1A8 administration, neutrophils were significantly depleted in the peripheral 
blood of mice who received antibody when compared to mice who did not receive antibody.  Testing to 
determine statistical significance between treatment groups at each time point was conducted using an 
unpaired two-tailed t test. (p < .05*) (p < .01**) (p < .001***) 
Figure 10: IT elastase administration 24 hours after a single 500 µg injection of 1A8 antibody does not 
affect 1A8-mediated systemic neutrophil depletion. 16 µL of tail vein blood was taken from each mouse at 








Next we wanted to determine if IT administration of elastase had any impact on 
the efficacy of the 1A8 antibody in depleting neutrophils (Figure 10).  Peripheral blood 
neutrophil levels over time measured in tail vein blood from animals treated with 
elastase 24 hours after administration of 1A8 antibody were not significantly different 
from the animals that received only 1A8 treatment. 
 
Cell Dynamics – Effects of Neutrophil Depletion on the BAL Fluid 
Figure 11 combines results for neutrophil (Figure 12), macrophage (Figure 13), 
and lymphocyte (Figure 14) BAL dynamics for comparison both between cell types and 
between treatment groups.  1A8 alters neutrophil dynamics in the five day period 









Neutrophil Dynamics  
Neutrophil depletion in the peripheral circulation in response to 1A8 injection 
was paralleled by a lack of neutrophil infiltrate in the lungs (Figure 12).  BALs from 
Figure 11: A 500 µg IP injection 
of 1A8 24 hours prior to IT 
elastase challenge affects 
neutrophil dynamics in the 
BAL, but not macrophage or 
lymphocyte dynamics. BAL 
samples were taken at days 1, 
3, and 5 post-PPE.  Each point 




neutrophil-depleted mice had an average of 2,607 neutrophils on day 1 post-PPE (SEM: 
621), versus 28,498 neutrophils in BAL samples from elastase-only treated mice (SEM: 
13,740).  While not significant due to variation between mice (p = 0.1330), this trend 









By day 5 elastase-only treated mice had neutrophil levels comparable to those of 
1A8-treated mice, leading us to conclude that neutrophils do not rebound within the 
window of neutrophil influx recorded after elastase challenge (Figure 6).  Importantly, 
this shows that 1A8 treatment alters the acute immune response to IT elastase by 
removing the key cell type in the protease-antiprotease hypothesis from the lung 
environment. 
In this experiment neutrophil counts from the BAL fluid of elastase-only treated 
mice were dramatically lower (28,498) than those from previous experiments (298,530).  
This ten-fold difference was due to fewer total cells being isolated from the BAL fluid 
and not from the reported percentage of neutrophils, which remain quite comparable.  
Figure 12:  Systemic neutrophil 
depletion with 1A8 antibody 
prevents the post-PPE 
neutrophil influx into the lung. 
1A8 was administered 24 
hours before elastase 
challenge, and BAL samples 
were taken at days 1, 3, and 5 
post-PPE.  Each point 





This reduction in total BAL cells also affects macrophage and lymphocyte numbers, 
which will be presented next. 
 









There was no significant difference between macrophage and monocyte 
numbers in the BAL fluid of 1A8-treated versus elastase-only treated mice at any time 
point post-PPE (Figure 13).  Mononuclear cell numbers for 1A8-treated mice were 
141,993 (day 1), 359,339 (day 3), and 264,793 (day 5).  The corresponding numbers for 
elastase-only treated mice were 141,992 (day 1), 251,348 (day 3), and 209,299 (day 5).  
When mononuclear cells are reported as a percent of BAL cells there is no significant 
difference between experiments (data not shown).  Importantly, the trend that 
macrophages and monocytes peak between 48 and 72 hours, and do not efflux by day 5 
is still there. 
 
Figure 13: Systemic neutrophil 
depletion with 1A8 antibody 
does not significantly affect 
the macrophage influx into the 
lungs at day 1, 3, or 5 post-
PPE. 1A8 was administered 24 
hours before elastase 
challenge. Each point 














There was no significant difference in BAL lymphocyte counts between 1A8-
treated and elastase-only treated mice (Figure 14).  Lymphocyte numbers for 1A8-
treated mice were 8,326 (day 1 post-PPE), 43,421 (day 3), and 12,747 (day 5) (n=3).  The 
corresponding numbers for elastase-only treated mice were 15,337 (day 1), 18,415 (day 
3), and 9,170 (day 5) (n=3).  This trend agrees with lymphocyte results from the first 
experiment. 
 
Total Cell Count Dynamics 
  Cell counts obtained from elastase-only treated mice on days 1, 3, and 5 post-
PPE were 224,800, 356,700, and 258,300 respectively (counts represent the average of 
three mice).  Cell counts of mice that received 1A8 antibody (day 1: 313,000, day 3: 
613,300, day 5: 338,300) were not significantly different from elastase-only treated mice 
on any day.  We conclude that depleting neutrophils does not appreciably change the 
Figure 14: Systemic neutrophil 
depletion with 1A8 antibody 
does not affect lymphocyte 
dynamics in the BAL at day 1, 
3, or 5 post-PPE. 1A8 was 
administered 24 hours before 
elastase challenge. Each point 




magnitude of the cellular influx in response to IT elastase.  This seemingly 
counterintuitive result will be addressed in the Discussion section. 
 









Blood in the BAL fluid as measured by the hemoglobin content of the BAL was 
not significantly different between treatment groups at any time point post-PPE (Figure 
15).  The observed trend followed an expected pattern – bloody BAL samples at early 
time points post-PPE that clear as time progresses, reaching baseline blood BAL levels by 
day 5.  This result suggests that neutrophil depletion does not significantly affect the 
level of acute damage done by elastase that leads to hemorrhage or the time course for 




Figure 15:  Hemoglobin in the BAL. A 
500 µg injection of 1A8 antibody 24 
hours prior to elastase challenge had 
no significant effect on lung 
hemorrhage as reported by 405 
absorbance. The BALs of elastase-
only treated and 1A8-treated mice 
were compared at days 1, 3, and 5 
post-PPE.  (n = 3)   
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Figure 16:  Edema was evaluated in 
mice that did not receive elastase 
(untreated), mice that received only 
elastase (PPE), and mice that received 
500 µg of 1A8 24 hours before elastase 
(PPE + 1A8). (a) shows W:D ratios of 
lungs resected 3 days post-PPE.  Wet 
(b) and dry(c) lung weights are graphed 
separately. (n = 5) 
 
Edema is significantly elevated in 
groups that received elastase (PPE and 
1A8 + PPE) compared to mice that did 
not receive elastase (b). Neutrophil 
depletion does not significantly affect 
lung edema after elastase challenge (b). 
 















Edema is an indirect measure of acute 
damage and the wet-to-dry (W:D) ratio is a common way to quantify it.  In the lungs, 
elastase-mediated damage results in an influx of plasma (edema) and other blood 
constituents, both of which are reflected in an increase in wet lung weight, and drying 
the lung removes the weight due to fluid accumulation.  Copious edema elevates the 
W:D ratio; and thus, similar to blood in the BAL, W:D lung ratios can be used to report 






treated mice had significantly higher W:D ratios when compared to either the PPE (p = 
0.0118) or control group (p = 0.0059) (Figure 16a).  This result was not consistent with 
the other measure of hemorrhage (hemoglobin, Figure 15), which suggested that there 
was not a difference in the level of damage.  In addition, unexpectedly, there was no 
significant difference between the PPE group – who received only elastase – and 
untreated mice – who received no elastase.  To address these inconsistencies, we 
considered the wet and dry lung weights separately.  After controlling for mouse weight, 
PPE mice were observed to have both heavier wet (Figure 16b) and dry (Figure 16c) 
lungs.  This suggests that the W:D ratio is not a suitable measure of lung edema at day 3 
following IT elastase. 
 









To assess the impact that neutrophil depletion had on the development of 
emphysema in BALB/c mice, lungs were harvested from neutrophil-depleted and control 
Figure 17:  Neutrophil depletion with 
a single 500 µg injection of 1A8 
antibody 24 hours prior to elastase 
challenge had no significant effect on 
airspace size 21 days post-PPE.  Lm 
values, calculated from formalin-
fixed H&E-stained histology sections, 
of elastase-only treated mice (n = 24) 
were not significantly different from 
those of 1A8-treated mice (n = 23).  
The number of mice per group has 
been pooled from five replicates. 
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animals at day 21 post-elastase and assessed histologically for the extent of alveolar 
damage.  In addition to visual inspection of the sections, mean chord lengths (Lm) were 
measured.  Combining the data from five independent replicate experiments, twenty-
four elastase-only treated mice had an average Lm score of 55.40 (range: 35.97 – 74.56) 
(SEM: 1.645) and twenty-three neutrophil-depleted mice had an average score of 61.04 
(range: 41.32 – 91.79) (SEM: 3.010) (Figure 17).  This difference in mean airspace chord 
length did not reach statistical significance (p = 0.1031); thus, by this measure, we 
concluded that neutrophils do not play a significant role in the regulation of elastase-














Figure 18:  Representative samples of H&E stained lung histology sections viewed with a 10X objective lens 
and taken from an untreated mouse (a), an elastase-only treated mouse (b), and an elastase and 1A8-
treated mouse (c).  Lungs were resected at 21 days post-PPE. Note differences in the volume-to-surface 
area ratio. (a) has a low Lm value, while (b) and (c) have high Lm values. This underlying pathology is 














While the presence of neutrophils did not appear to influence the elastase-
induced lung damage, it is possible that it does impact lung function.  DFCO measures the 
gas exchange capacity of the lung – low values indicate impeded gas exchange and can 
be due to decreased surface area, as in emphysema, or interstitial thickening, as in 
asthma.  DFCO values of 1A8-treated mice 21 days post-PPE were not significantly 







Figure 20:  Neutrophil depletion with 
a single 500 µg injection of 1A8 
antibody 24 hours prior to elastase 
challenge had no significant effect on 
lung volume 21 days post-PPE. TLC 
values of elastase-only treated mice (n 
= 19) were not significantly different 
from those of 1A8-treated mice (n = 
21).  The number of mice per group 
has been pooled from four replicates. 
 
Figure 19:  Neutrophil 
depletion with a single 500 
µg injection of 1A8 antibody 
24 hours prior to elastase 
challenge had no significant 
effect on lung function 21 
days post-PPE.  DFCO values 
of elastase-only treated 
mice (n = 20) were not 
significantly different from 
those of 1A8-treated mice (n 
= 21).  The number of mice 
per group has been pooled 
from four replicates. 
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Another measure of lung function is total lung capacity (TLC).  TLC is elevated in 
emphysema due to parenchymal destruction and it correlates with the increasing 
airspace seen in lung histology sections.  TLC measurements were not significantly 
different between 1A8-treated mice and control animals (p = 0.4180) (Figure 20).  This 
agrees with our previous Lm data and supports the conclusion that neutrophil depletion 














Our experiments were designed to test the hypothesis that the early influx of 
neutrophils into the lungs (A) contributes to the resolution of acute elastase-mediated 
injury and (B) affords protection to the lungs from the progressive alveolar destruction 
that is associated with emphysema.   
 
Our experiments in BALB/c mice are the first report of neutrophil, macrophage, 
lymphocyte, and total cell BAL dynamics over early and late time points in the acute 
response to three units of IT elastase.  The early and transitory presence of neutrophils 
was confirmed, and contrasted with the delayed and prolonged presence of 
macrophages.  This is not significantly different from the cellular dynamics observed in 
C57BL/6 mice receiving either 6U or 3U of elastase.  Neutrophils arrive rapidly within 
one hour post-PPE, peak between 24 and 48 hours, begin to fall by 72 hours, and are at 
pre-challenge levels five days after the inciting stimulus.  These data established the 
time frame that was critical for testing the hypothesis that neutrophil recruitment to the 
lungs impacts the short-term and long-term consequences of elastase-induced 
pulmonary damage. 
We found that a single 500 µg dose of the anti-Ly6G antibody, 1A8, 24 hours 
prior to elastase administration was sufficient to sustain a profound neutropenia in the 
peripheral blood over the entire dynamic period post-elastase challenge when control 
animals see a significant influx of neutrophils.  The test and control animals tolerated 
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1A8 treatment well suggesting that transient neutrophil depletion had minimal impact 
on overall health. 
Based on the role that neutrophils play in wound repair and tissue remodeling in 
other tissues (25), we hypothesized that the presence of neutrophils after elastase 
administration would play a role in limiting the extent of damage and promote repair.  
The observation that the amount of blood in the BAL fluid (used here as a marker of 
acute damage to the alveolar epithelium and endothelium resulting in hemorrhage) as 
well as the duration of blood in the BAL (used as a surrogate for how rapidly the damage 
was repaired) did not change significantly in response to neutrophil depletion suggested 
one of two things.  First, in our model the high dose of elastase administered to each 
mouse might cause damage so extensive and immediate in nature as to mask any acute 
amelioration from neutrophils.  Second, it is possible that these ameliorating effects 
from neutrophils might only manifest later during the chronic resolution phase.  The 
conclusion that neutrophil depletion did not significantly alter the level of elastase-
induced damage was also supported by the lung W:D data.  Additional studies are 
needed to define the roles of neutrophils in the resolution of acute tissue damage in the 
lungs.  
It was anticipated that as a result of neutrophil depletion there would be an 
alteration in the number, dynamics and composition of the cellular infiltrate associated 
with elastase-induced damage in the lungs.  Unexpectedly, the total number of cells 
measured in the BAL in response to elastase challenge as well as the composition of the 
cellular infiltrate were not significantly affected by neutrophil-depletion.  The reasons 
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for this unexpected outcome are not clear.  One factor that influenced the results was a 
high level of experimental variation in cell counts.  High standard errors were obtained 
for total cell counts within experiments; and additionally, significant differences existed 
in cell counts between experiments.  The total number of cells isolated from BAL 
samples was reduced in the antibody depletion experiment.  Cell counts obtained from 
elastase-only treated mice on days 1, 3, and 5 were 224,800, 356,700, and 258,300 
respectively.  Day 1, 3, and 5 counts from earlier experiments (see Figure 6) were 
817,500, 1,983,333, and 1,367,500 respectively.  The reasons for this variation in cell 
counts is unclear.  Variability in the BAL cellular response to IT elastase could be due to 
variable dosing, variable delivery to the various lobes of the lungs, variable enzymatic 
activity, and/or natural variations between mice.  However, because no significant 
difference in total cell counts was observed between neutrophil-depleted and 
neutrophil-intact mice after antibody-mediated neutrophil depletion we conclude that 
the presence of neutrophils in damaged lung tissues does not appreciably influence the 
magnitude or the cellular composition of the cellular influx in response to IT elastase. 
This conclusion seems at odds with our understanding of the consequences of 
treatment with the neutrophil-depleting 1A8 antibody.  1A8 depletes a cell type 
common in post-PPE BAL samples, which should affect the total cell counts.  One 
interpretation of this is that variation between mice keeps the small reduction in total 
cells due to 1A8 statistically insignificant.  Recall from earlier results that neutrophils are 
not the primary cell type isolated from BAL fluid – macrophages are.  Because total BAL 
63 
 
cell counts are used to calculate absolute neutrophil, macrophage, and lymphocyte 
numbers, total cell variability is reflected in all cell quantification data.   
We have shown that macrophage numbers increase in the lungs – whether due 
to local proliferation or systemic recruitment – in response to IT elastase, peak around 
48 to 72 hours post-PPE and remain elevated throughout the acute 5-day period.  Of 
interest is the observation that neutrophil depletion does not significantly affect 
macrophage dynamics, offering the possibility that recruitment and signaling between 
neutrophils and macrophages in the elastase model is largely one-way.  However, until 
the effector profile of the lung macrophage population is examined in both a neutrophil-
intact and a neutrophil-depleted response to IT elastase the possibility remains that 
neutrophil depletion protects mice from emphysema through its indirect impact on 
macrophages. 
Lymphocytes are relatively scarce in the lung at all time points post-PPE 
suggesting any lymphocyte involvement in emphysema would occur later outside of the 
acute response.  This agrees with our understanding of the biology of lymphocytes and 
their roles in adaptive immune response. 
The main hypothesis of this study that neutrophils are protective and that 
neutrophil depletion would result in an increase in the level of emphysema was not 
supported by the data.  The results compiled from five independent experimental 
replicate cohorts that measured mean airspace chord length (Lm), the diffusion 
coefficient (DFCO), and TLC demonstrated that neutrophil depletion did not significantly 
affect the degree of elastase-induced emphysema as measured at day 21.  These results 
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prompt a reevaluation of the possible roles that neutrophils play in the induction and 
progression of emphysema. 
 
The phenotype associated with an alpha 1-antitrypsin deficiency and the 
impressive degree to which neutrophil elastase KO mice are protected from emphysema 
have been used to justify the elastase model (56).  But problems with the elastase 
model are evident – there is no reproduction of the cigarette smoke exposure and 
hypoxic conditions.  It was previously discussed that cigarette smoke and hypoxia alter 
the phenotype of effector cells (2) (37).  Cigarette smoke likely plays a role not 
accounted for in the elastase model of emphysema; and thus extrapolation of research 
in the elastase model to human emphysema is not straightforward. 
Remembering that cigarette smoke is the strongest risk factor for the 
development of emphysema in humans, that the lungs of smokers are exposed to 
cigarette smoke often many times in one day, and that cigarette smoke interferes with 
the normal apoptosis and clearance of neutrophils from sites of sterile damage (2) it is 
reasonable to question whether such a “neutrophil window” exists in emphysema 
patients.  These factors would only increase the amount of time neutrophils are 
activated in the lung.  If no significant differences in alveolar destruction (Lm) and lung 
function (TLC and DFCO) are seen when neutrophils are present for a short time (i.e. 
elastase model), it is possible that neutrophils play a bigger role under conditions of 
chronic exposure (i.e. long-term smokers). 
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Elevated neutrophil counts in the airway and sputum correlate with the rate of 
declining lung function and the extent of peripheral airway dysfunction, respectively (2).  
Despite overwhelming evidence for neutrophilia and neutrophil elastase in smoker 
sputum and bronchioles (2), it is suspect that neutrophils are not particularly prevalent 
in biopsies of the lung parenchyma – where the alveolar destruction actually occurs (4).  
Also suspect is the transitory presence of neutrophils relative to other effector cells.  If 
we consider Occam’s razor and the law of parsimony, it is most likely that the effector 
mechanisms responsible for a chronic disease like emphysema should be present 
throughout disease initiation, progression, and should disappear if and when the 
disease resolves or progression slows. 
Ultimately, the experimental evidence presented here using the BALB/c model 
indicates neutrophils do not significantly contribute to the development of emphysema.  
Measurements of alveolar destruction, functional surface area for gas exchange, and 
lung volume all show that neutrophil depletion is not protective.  Our findings give 
credence to theories supporting the involvement of other immune cells.  Many of these 
theories were discussed in the introduction.  In brief, they evidenced the potential 
importance of macrophages and the prospect of autoimmune involvement.  A 1999 
neutrophil depletion study in cigarette smoked rats also concluded that neutrophils 
were not important in the pathogenesis of emphysema (61).  Clinical observations that 
many antiprotease drugs – some targeting neutrophil elastase – have failed to stem the 
progression of emphysema agree with our findings.  Most importantly, one 
interpretation of our data puts a dent in the prevailing protease-antiprotease hypothesis 
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– emphysema is not a disease of renegade neutrophil elastase.   Another interpretation 
is that the BALB/c elastase model is not suitable for studying emphysema.  Neutrophil 
depletion in other animal models of emphysema is certainly justified and will help put 
these results in perspective. 
Clearly, emphysema is a complex, multifactorial disease and there is much work 
still to be done.  In conclusion, this research contributes to the field in a novel way by 
directly showing no diminution of disease when neutrophils are systemically depleted at 





1. Abboud RT, Vimalanathan S. Pathogenesis of COPD. part I. the role of protease-
antiprotease imbalance in emphysema. Int J Tuberc Lung Dis. 2008 
Apr;12(4):361-7.  
2. Hoenderdos K, Condliffe A. The neutrophil in chronic obstructive pulmonary 
disease. Am J Respir Cell Mol Biol. 2013 May;48(5):531-9.  
3. Kheradmand F, Shan M, Xu C, Corry DB. Autoimmunity in chronic obstructive 
pulmonary disease: Clinical and experimental evidence. Expert Rev Clin 
Immunol. 2012 Mar;8(3):285-92.  
4. Barnes PJ, Shapiro SD, Pauwels RA. Chronic obstructive pulmonary disease: 
Molecular and cellular mechanisms. European Respiratory Journal. 
2003;22(4):672-88.  
5. Chronic Obstructive Pulmonary Disease (COPD) Fact Sheet. American Lung 
Association [Internet]. 2013 Aug.  
6. Kemp SV, Polkey MI, Shah PL. The epidemiology, etiology, clinical features, and 
natural history of emphysema. Thorac Surg Clin. 2009 May;19(2):149-58.  
7. Marsland BJ, Kurrer M, Reissmann R, Harris NL, Kopf M. Nippostrongylus 
brasiliensis infection leads to the development of emphysema associated with 
the induction of alternatively activated macrophages. Eur J Immunol. 2008 
Feb;38(2):479-88.  
8. Retamales I, Elliott W, Meshi B, Coxson H, Pare P, Sciurba F, et al. Amplification 
of inflammation in emphysema and its association with latent adenoviral 
infection. Am J Respir Crit Care Med. 2001;164:469-73.  
9. Kryfti M, Bartziokas K, Papaioannou AI, Papadopoulos A, Kostikas K. Clinical 
effectiveness of macrolides in diseases of the airways: Beyond the antimicrobial 
effects. Pneumon. 2013;26(1):33-46.  
10. Liu-Bryan R, Scott P, Sydlaske A, Rose DM, Terkeltaub R. Innate immunity 
conferred by toll-like receptors 2 and 4 and myeloid differentiation factor 88 
expression is pivotal to monosodium urate monohydrate crystal-induced 
inflammation. Arthritis Rheum. 2005 Sep;52(9):2936-46.  
11. Cavassani KA, Ishii M, Wen H, Schaller MA, Lincoln PM, Lukacs NW, et al. TLR3 
is an endogenous sensor of tissue necrosis during acute inflammatory events. J 
Exp Med. 2008 Oct 27;205(11):2609-21.  
12. Jensen JA, Goodson WH, Hopf HW, Hunt TK. Cigarette smoking decreases tissue 
oxygen. Archives of Surgery. 1991;126(9):1131-4.  
13. Chen GY, Nunez G. Sterile inflammation: Sensing and reacting to damage. Nat 
Rev Immunol. 2010 Dec;10(12):826-37.  
68 
 
14. Dostert C, Petrilli V, Van Bruggen R, Steele C, Mossman BT, Tschopp J. Innate 
immune activation through Nalp3 inflammasome sensing of asbestos and silica. 
Science. 2008 May 2;320(5876):674-7.  
15. Fukumoto J, Fukumoto I, Parthasarathy PT, Cox R, Huynh B, Ramanathan GK, et 
al. NLRP3 deletion protects from hyperoxia-induced acute lung injury. American 
Journal of Physiology - Cell Physiology. 2013;305(2):C182-9.  
16. Chen C-, Shi Y, Hearn A, Fitzgerald K, Golenbock D, Reed G, et al. MyD88-
dependent IL-1 receptor signaling is essential for gouty inflammation 
stimulated by monosodium urate crystals. J Clin Invest. 2006;116(8):2262-71.  
17. Vayssier M, Banzet N, Francois D, Bellmann K, Polla BS. Tobacco smoke induces 
both apoptosis and necrosis in mammalian cells: Differential effects of HSP70. 
Am J Physiol. 1998 Oct;275(4 Pt 1):L771-9.  
18. Chen C-, Kono H, Golenbock D, Reed G, Akira S, Rock KL. Identification of a key 
pathway required for the sterile inflammatory response triggered by dying 
cells. Nat Med. 2007;13(7):851-6.  
19. Rovina N, Koutsoukou A, Koulouris NG. Inflammation and immune response in 
COPD: Where do we stand? Mediators Inflamm. 2013;2013:413735.  
20. Lotze MT, Zeh HJ, Rubartelli A, Sparvero LJ, Amoscato AA, Washburn NR, et al. 
The grateful dead: Damage-associated molecular pattern molecules and 
reduction/oxidation regulate immunity. Immunol Rev. 2007;220(1):60-81.  
21. Kolaczkowska E, Kubes P. Neutrophil recruitment and function in health and 
inflammation. Nat Rev Immunol. 2013 Mar;13(3):159-75.  
22. Churg A, Wang RD, Tai H, Wang X, Xie C, Wright JL. Tumor necrosis factor-a 
drives 70% of cigarette smoke-induced emphysema in the mouse. American 
Journal of Respiratory and Critical Care Medicine. 2004;170(5):492-8.  
23. Al-Kassimi FA, Alhamad EH. A challenge to the seven widely believed concepts 
of COPD. Int J Chron Obstruct Pulmon Dis. 2013;8:21-30.  
24. Amulic B, Cazalet C, Hayes GL, Metzler KD, Zychlinsky A. Neutrophil function: 
From mechanisms to disease. Annu Rev Immunol. 2012;30:459-89.  
25. Mantovani A, Cassatella MA, Costantini C, Jaillon S. Neutrophils in the 
activation and regulation of innate and adaptive immunity. Nat Rev Immunol. 
2011 Jul 25;11(8):519-31.  
26. Takahashi T, Hato F, Yamane T, Fukumasu H, Suzuki K, Ogita S, et al. Activation 
of human neutrophil by cytokine-activated endothelial cells. Circ Res. 2001 Mar 
2;88(4):422-9.  
27. Heit B, Tavener S, Raharjo E, Kubes P. An intracellular signaling hierarchy 
determines direction of migration in opposing chemotactic gradients. J Cell 
Biol. 2002;159(1):91-102.  
69 
 
28. Witko-Sarsat V, Rieu P, Descamps-Latscha B, Lesavre P, Halbwachs-Mecarelli L. 
Neutrophils: Molecules, functions and pathophysiological aspects. Lab Invest. 
2000 May;80(5):617-53.  
29. Jenne CN, Wong CH, Zemp FJ, McDonald B, Rahman MM, Forsyth PA, et al. 
Neutrophils recruited to sites of infection protect from virus challenge by 
releasing neutrophil extracellular traps. Cell Host Microbe. 2013 Feb 
13;13(2):169-80.  
30. Anthony RM, Rutitzky LI, Urban JF,Jr, Stadecker MJ, Gause WC. Protective 
immune mechanisms in helminth infection. Nat Rev Immunol. 2007 
Dec;7(12):975-87.  
31. Segal AW. How neutrophils kill microbes. Annu Rev Immunol. 2005;23:197-223.  
32. Isik B, Ceylan A, Isik R. Oxidative stress in smokers and non-smokers. Inhal 
Toxicol. 2007 Jul;19(9):767-9.  
33. Shapiro SD, Goldstein NM, Houghton AM, Kobayashi DK, Kelley D, Belaaouaj A. 
Neutrophil elastase contributes to cigarette smoke-induced emphysema in 
mice. Am J Pathol. 2003 Dec;163(6):2329-35.  
34. Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, et al. 
Neutrophil extracellular traps kill bacteria. Science. 2004 Mar 
5;303(5663):1532-5.  
35. Tadie JM, Bae HB, Jiang S, Park DW, Bell CP, Yang H, et al. HMGB1 promotes 
neutrophil extracellular trap formation through interactions with toll-like 
receptor 4. Am J Physiol Lung Cell Mol Physiol. 2013 Mar 1;304(5):L342-9.  
36. Farrera C, Fadeel B. Macrophage clearance of neutrophil extracellular traps is a 
silent process. J Immunol. 2013 Sep 1;191(5):2647-56.  
37. Richens TR, Linderman DJ, Horstmann SA, Lambert C, Xiao YQ, Keith RL, et al. 
Cigarette smoke impairs clearance of apoptotic cells through oxidant-
dependent activation of RhoA. Am J Respir Crit Care Med. 2009 Jun 
1;179(11):1011-21.  
38. Borges VM, Vandivier RW, McPhillips KA, Kench JA, Morimoto K, Groshong SD, 
et al. TNFalpha inhibits apoptotic cell clearance in the lung, exacerbating acute 
inflammation. Am J Physiol Lung Cell Mol Physiol. 2009 Oct;297(4):L586-95.  
39. Ginzberg HH, Cherapanov V, Dong Q, Cantin A, McCulloch CA, Shannon PT, et 
al. Neutrophil-mediated epithelial injury during transmigration: Role of 
elastase. Am J Physiol Gastrointest Liver Physiol. 2001 Sep;281(3):G705-17.  
40. Zemans RL, Briones N, Campbell M, McClendon J, Young SK, Suzuki T, et al. 
Neutrophil transmigration triggers repair of the lung epithelium via beta-
catenin signaling. Proc Natl Acad Sci U S A. 2011 Sep 20;108(38):15990-5.  
70 
 
41. Sieweke MH, Allen JE. Beyond stem cells: Self-renewal of differentiated 
macrophages. Science. 2013 Nov 22;342(6161):1242974.  
42. Hashimoto D, Chow A, Noizat C, Teo P, Beasley MB, Leboeuf M, et al. Tissue-
resident macrophages self-maintain locally throughout adult life with minimal 
contribution from circulating monocytes. Immunity. 2013 Apr 18;38(4):792-
804.  
43. Pappas K, Papaioannou AI, Kostikas K, Tzanakis N. The role of macrophages in 
obstructive airways disease: Chronic obstructive pulmonary disease and 
asthma. Cytokine. 2013 Dec;64(3):613-25.  
44. Chung KF, Adcock IM. Multifaceted mechanisms in COPD: Inflammation, 
immunity, and tissue repair and destruction. Eur Respir J. 2008 Jun;31(6):1334-
56.  
45. Hautamaki RD, Kobayashi DK, Senior RM, Shapiro SD. Requirement for 
macrophage elastase for cigarette smoke-induced emphysema in mice. 
Science. 1997;277(5334):2002-4.  
46. Kang MJ, Homer RJ, Gallo A, Lee CG, Crothers KA, Cho SJ, et al. IL-18 is induced 
and IL-18 receptor alpha plays a critical role in the pathogenesis of cigarette 
smoke-induced pulmonary emphysema and inflammation. J Immunol. 2007 Feb 
1;178(3):1948-59.  
47. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, et al. The nature 
of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J 
Med. 2004 Jun 24;350(26):2645-53.  
48. Grumelli S, Corry DB, Song LZ, Song L, Green L, Huh J, et al. An immune basis for 
lung parenchymal destruction in chronic obstructive pulmonary disease and 
emphysema. PLoS Med. 2004 Oct;1(1):e8.  
49. Shan M, Cheng HF, Song LZ, Roberts L, Green L, Hacken-Bitar J, et al. Lung 
myeloid dendritic cells coordinately induce TH1 and TH17 responses in human 
emphysema. Sci Transl Med. 2009 Oct 28;1(4):4ra10.  
50. Lee SH, Goswami S, Grudo A, Song LZ, Bandi V, Goodnight-White S, et al. 
Antielastin autoimmunity in tobacco smoking-induced emphysema. Nat Med. 
2007 May;13(5):567-9.  
51. Taraseviciene-Stewart L, Scerbavicius R, Choe KH, Moore M, Sullivan A, Nicolls 
MR, et al. An animal model of autoimmune emphysema. Am J Respir Crit Care 
Med. 2005 Apr 1;171(7):734-42.  
52. Maeno T, Houghton AM, Quintero PA, Grumelli S, Owen CA, Shapiro SD. CD8+ T 
cells are required for inflammation and destruction in cigarette smoke-induced 
emphysema in mice. Journal of Immunology. 2007;178(12):8090-6.  
71 
 
53. D'hulst AI, Maes T, Bracke KR, Demedts IK, Tournoy KG, Joos GF, et al. Cigarette 
smoke-induced pulmonary emphysema in scid-mice. is the acquired immune 
system required? Respir Res. 2005 Dec 16;6:147.  
54. Crapo JD, Barry BE, Gehr P, Bachofen M, Weibel ER. Cell number and cell 
characteristics of the normal human lung. Am Rev Respir Dis. 1982 
Aug;126(2):332-7.  
55. Chen L, Wang T, Guo L, Shen Y, Yang T, Wan C, et al. Overexpression of RAGE 
contributes to cigarette smoke-induced nitric oxide generation in COPD. Lung. 
2014 Apr;192(2):267-75.  
56. Antunes MA, Rocco PR. Elastase-induced pulmonary emphysema: Insights from 
experimental models. An Acad Bras Cienc. 2011 Dec;83(4):1385-96.  
57. Mitzner W. Use of mean airspace chord length to assess emphysema. J Appl 
Physiol (1985). 2008 Dec;105(6):1980-1.  
58. Glaab T, Vogelmeier C, Buhl R. Outcome measures in chronic obstructive 
pulmonary disease (COPD): Strengths and limitations. Respir Res. 2010 Jun 
17;11:79,9921-11-79.  
59. Fournier BM, Parkos CA. The role of neutrophils during intestinal inflammation. 
Mucosal Immunol. 2012 Jul;5(4):354-66.  
60. Bozinovski S, Uddin M, Vlahos R, Thompson M, McQualter JL, Merritt AS, et al. 
Serum amyloid A opposes lipoxin A(4) to mediate glucocorticoid refractory lung 
inflammation in chronic obstructive pulmonary disease. Proc Natl Acad Sci U S 
A. 2012 Jan 17;109(3):935-40.  
61. Ofulue AF, Ko M. Effects of depletion of neutrophils or macrophages on 
development of cigarette smoke-induced emphysema. Am J Physiol. 1999 
Jul;277(1 Pt 1):L97-105.  
62. Knudsen L, Weibel ER, Gundersen HJ, Weinstein FV, Ochs M. Assessment of air 
space size characteristics by intercept (chord) measurement: An accurate and 
efficient stereological approach. J Appl Physiol (1985). 2010 Feb;108(2):412-21.  
63. Soutiere SE, Mitzner W. On defining total lung capacity in the mouse. J Appl 
Physiol (1985). 2004 May;96(5):1658-64.  
64. Fallica J, Das S, Horton M, Mitzner W. Application of carbon monoxide diffusing 














Johns Hopkins Bloomberg School of Public Health – Baltimore, MD      Aug ‘12 – Present 
GPA: 3.76              Expected Graduation May 2014 
Masters of Science (ScM) in Molecular Microbiology and Immunology 
Thesis Research: The dynamics and role of neutrophils in an elastase 
model of emphysema 
Principal Investigator and Thesis Advisor: Alan Scott, Ph.D. 
 
Rotation Research: Investigating novel metabolism-based compounds for 
the treatment of epilepsy 
Principal Investigator: Adam Hartman, M.D.  
 
 The Certificate in Vaccine Science and Policy, Dept. of International Health 
 
Texas A&M University (TAMU) – College Station, TX                                 Aug ‘08 – Aug ‘12 
 GPA: 3.615         Graduated Aug 2012 
Bachelor of Science in Biomedical Science (BIMS) 
    
  
Work Experience   
 
TAMU Dept. of Veterinary Pathobiology – College Station, TX                Aug ‘11 – Aug ‘12 
Microbiology Lab Teaching Assistant 
 Supervise students and enforce lab safety 
 Teach students the theory behind and techniques associated with 
biochemical tests specific for bacteria 
 
TAMU Student Learning Center – College Station, TX                                Jan ‘10 – May ‘12 
 Organic chemistry, Zoology Supplemental Instruction (SI) Leader 
 Lead and organize group study sessions 
 Prepare worksheets and practice problems 
 Review material with students who elect to attend 
 Introduce new study habits and learning methodology to students 
 
Catherine C Bradley 
Date of birth: June 29, 1990 
Place of birth: Houston, TX 
 
Cell phone:  281-770-6859 
Email:  cbradley@jhsph.edu 
Address (current):  1101 N Calvert St., Apt. 1801 




Volunteer Work      
 
Johns Hopkins Hospital – Baltimore, MD             July ‘13 – Dec ‘13 
 Student Volunteer 
 shadow David Feller-Kopman, M.D. to gain a better knowledge of 
interventional pulmonology, teaching hospital operations, and 
emphysema – the subject of my Master’s thesis work 
 
Chemistry Road Show (organized through TAMU) – TX               Nov ‘11 
Chemistry Road Show Assistant 
 travel to local schools and assist James Pennington, Ph.D. in chemistry 
demonstrations designed to stimulate an interest in science among 
students 
 
OB/GYN Affiliates of Katy – Katy, TX                                                             May ‘11 – Aug ‘11 
 Student Volunteer 
 shadow Selina Lin, M.D. to gain a better knowledge of common OB/GYN 
health practices, doctor-patient relations, and the business side of 
medicine  
 take patient vital signs 
 
College Station Medical Center – College Station, TX                                Aug ‘10 – May ‘11 
 Aggieland Volunteer 
 assist the nursing staff of the cardiac care unit with filing, other 
secretarial work, and nonmedical patient care 





TAMU Dept. of Veterinary Pathobiology – College Station, TX        May ‘12 – Aug ‘12 
 Student Researcher 
 Research: Assembly and sequencing of the Avian Bornavirus genome 
 Principal Investigator: Susan Payne, Ph.D. 
 
BIMS Directed Studies – College Station, TX                                                 Jan ‘11 – May ‘11 
Biomedical Microbiology Lab 485 
 one of a small number of students selected to train as future 
microbiology lab teaching assistants 
 assist in the demonstration of laboratory techniques and help teach the 




Research Skills  
 
PCR 
Bacterial culture and cloning 
Western blotting 
Primary cell isolation 
Histological processing 
Mouse handling and dissections 
 
Research Interests 
Innate immunology and inflammation 
Lung physiology and pathology 
 
